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The gut-brain connection refers to the bidirectional communication pathway between the brain 
and gastrointestinal (GI) system. Recent epidemiological research has suggested incidence rates 
of Disorders of Gut Brain Interaction (DGBI) in emerging adults are increasing. The goal of the 
study was to investigate the associations between the latent variables of GI health, psychological 
distress, and impairment in general functioning (disability) across two time points. Although the 
gut-brain connection has been established, research on its directionality and association with 
functioning in emerging adults remains an understudied area. A repeated measures design was 
used to collect data via an online survey in emerging adults (N = 861). Measurement equivalence 
across time was established for each of the three latent variables. A cross-lagged panel model 
(CLPM) was specified to explore reciprocal and directional influences. Three significant cross-
lagged paths were found. Higher levels of psychological distress at Time 1 predicted higher GI 
symptoms at Time 2. This cross-lagged effect lends preliminary evidence gastrointestinal 
symptoms may be a consequence of psychological distress in emerging adults. There was a 
significant cross-lagged effect between GI symptoms at Time 1 and disability at Time 2. A 
significant cross-lagged pathway from disability to distress was also found. The cross-lagged 
design and significant cross-lagged paths offer stronger causal inferences than the traditional 
cross-sectional design that is used to study the effects of GI symptoms. This study provides 
psychometric evidence for the use of a latent construct of GI health using the PROMIS-GI® 
subscales. Findings infer a directional pathway between the brain and the gut rather than a 
bidirectional network. This signaling seems to be stronger from the brain to the gut than the gut 
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CHAPTER ONE: INTRODUCTION  
The gut and the brain are in continuous communication. Many are familiar with the 
common sensation of “butterflies in the stomach” when experiencing anxiety or nerves. 
Additionally, the popular statement referring to intuitive decision making “based on your gut or 
having a gut feeling” also speaks to this relationship.  The ongoing pathways between the brain 
and the gut are referred to as the Gut-Brain connection. The Gut-Brain connection continues to 
be a captivating area of psychological and gastroenterological research. Further understanding 
the gut-brain axis (GBA) may yield recommendations for assessment and treatment of those with 
gastrointestinal (GI) and psychological difficulties. 
Biopsychosocial Model 
The psychosocial complexity of self-reported gastrointestinal symptoms remains an area 
of academic and clinical debate. The origins of this can be traced to the notion of dualism of the 
human body. Dualism, or the notion of mind and body as separate entities, was accepted by 
many until the rise of psychosomatic medicine. The premise of dualism was that the mind played 
no role in biological and physiological processes. Psychosomatic medicine posited that 
unconscious processes and psychological stress could manifest and be converted into physical 
diseases, referred to at the time as hysteria (Gottlieb, 2003; Nimnuan et al., 2001). Many physical 
illnesses once believed to have been caused by psychological states were disproven with medical 
advancements. Nonetheless, the mind-body debate continued with the formation of the 
biomedical model. The biomedical model focused on investigating for disease specificity within 
the body. Subsequently, the role of psychosocial processes was viewed as secondary and 





and early 1980’s that epidemiological studies revealed the importance of recognizing the mind 
and body as important influences of one another. Specifically, acknowledging the role of 
psychosocial factors, gastrointestinal symptoms, and illness behaviors. An investigation 
comparing irritable bowel syndrome (IBS) patients seeking treatment to non-clinical IBS patients 
in the 1980’s was one of the first to highlight psychosocial distress in relation to IBS. IBS is 
characterized by abdominal pain and abnormalities in stool form and frequency (Mearin et al., 
2016). The researchers found higher levels of psychosocial distress enabled symptom severity 
and illness behaviors. Higher levels of psychosocial distress led to increased healthcare seeking 
and an increased prevalence of psychological disturbances in IBS patients vs. non-IBS patients 
(Drossman, 1988; Tanaka et al., 2011; Whitehead et al., 1988). 
Our understanding of the bidirectional relationship between the mind and body was 
pioneered by George Ingel. George Ingel gave rise to the importance of understanding 
psychological and social factors that are associated with and play an important role in physical 
illness and diseases (Borrell-Carrió et al., 2004; Engel, 1977). The biopsychosocial model offers 
an alternative framework to the dualistic notion of the mind and body. It gave rise to 
considerations of psychological comorbidities, psychological states, and their influence on 
physical conditions and self-reported physical experiences, such as pain.  The biopsychosocial 
model offers several advantages over the biomedical model. Research has shifted its perspective 
to propose that illness is a byproduct of biological and psychosocial processes, and these 
subsystems interact at multiple levels over time. Subsequently, these systems will then determine 
the presence, severity, and duration of biological and aberrant somatic experiences. 
Psychological research has evolved to encompass a multidisciplinary approach to illness. This 





related quality of life and coping. In addition, there is an initiative to capture patient’s 
perceptions, behaviors, and include psychosocial assessments as standard of care in treatment 
protocols. It is now crucial to include multivariate statistical methods to investigate and control 
for interacting biopsychosocial variables in emerging research (Drossman & Hasler, 2016). 
Neglecting the interaction of these variables may be a disservice to patients, the discipline, and 
contributions to literature (Drossman & Hasler, 2016). 
The Gut-Brain Connection 
The bidirectional communication networks between the brain and the gut have been 
studied extensively. The scientific breakthrough of the connection between the nervous system 
and the digestive system is traced to the discovery of the enteric nervous system (ENS; (Mayer, 
2011). The ENS governs the function of the gastrointestinal tract and processes food and waste. 
It is estimated about 500 million neurons exist in the ENS, and these neurons communicate with 
the central nervous system (CNS) through many neurotransmitters, including dopamine and 
serotonin (Mayer, 2011; Mayer et al., 2015). The ENS and the CNS communicate and affect one 
another through neural pathways including the vagus nerve, the immune system, and the 
hypothalamic-pituitary-adrenal (HPA) axis (De Palma et al., 2014). As such, the combined 
functioning of our GI system and the CNS activity is conceptualized under the GBA model or 
gut-brain interaction (Foster & Neufeld, 2013). Within this framework, the gut is conceptualized 
by many to be the “new brain.” Hence, the gut’s millions of neurons and bacteria (microbiome) 
influence the brain’s health, and the brain’s functioning (i.e., anxiety, depression, or stress) can 
influence the gut’s well-being. Interestingly, as much as 90 percent of the hormone serotonin 





been empirically established stress can affect both the gut bacteria and this vital communicative 
system (De Palma et al., 2014; Mayer et al., 2015). In turn, the bidirectional pathways between 
the gut and the brain can be affected, and may trigger self-reported discomfort, bloating, and gas 
(Carabotti et al., 2015). The gastrointestinal (GI) system involves the brain, esophagus, stomach, 
large intestine, small intestine, and the rectum. It is hypothesized in clinical patient populations 
there might be a disturbance in this system. This could lead to a wide range of inflammatory and 
functional GI disorders, obesity, or psychological complaints (Lucas, 2018; Mayer, 2011; Van 
Oudenhove et al., 2016; Yukari et al., 2011).  
Measuring the Gut-Brain Connection 
There are several ways to assess gastrointestinal functioning. In patients with 
inflammatory bowel diseases (IBD) such as Celiac Disease or Ulcerative Colitis, diagnosing 
involves a gastroenterologist specialist. The diagnosis process may involve gastroenterological 
examination, serology, phenotypic analysis, and endoscopic biopsy (Bai & Ciacci, 2017). To 
assess for an individual’s self-appraisal of their gastrointestinal functioning as well as general 
impact of symptoms on an individual’s functioning, another avenue is utilizing Patient Reported 
Outcomes (PROs) via self-report measures. The National Institute of Health (NIH), in an 
initiative to create PRO measures of physical, mental, and social health domains, developed the 
Patient-Reported Outcomes Measurement Information System (PROMIS®;(Yount et al., 2019). 
This system consists of freely available, brief, and psychometrically valid PRO measures. The 
advantage of using PROs (i.e. self-report measures) is they can be easily implemented in 
academic campus health centers or primary care facilities as a part of a needs assessment, 





Additionally, repeated measures can be more easily acquired to assess for change over time. One 
study (Cassisi et al., 2020) illustrated that NIH PROs measurement systems could be easily 
implemented into the workflow of a gastroenterology clinic.  Another advantage of employing 
self-report measures is they capture an individual’s appraisal of their own symptom presentation, 
which will often be what they may verbally report to their physicians. Further, disorders of gut-
brain interaction (DGBI) do not have direct biological correlates for a diagnosis, so symptom 
classification using physiological tests would not be supported conceptually. This study does not 
include direct measures of GI system activity through physiological tests. However, self-report 
measures corresponding to these systems should correspond to GBA endpoints (Mayer et al., 
2015).  Since there is a physiological and biological theoretical underpinning to this study, it is 
plausible that stronger causal inferences can be made between GI health, psychological distress, 







CHAPTER TWO: LITERATURE REVIEW 
Disorders of Gut-Brain Interaction (DGBI) 
 
In a national GI survey, 61% of the community reported experiencing at least one  GI 
symptom per week and 58.4% of respondents reported co-occurring (i.e. two or more GI 
symptoms) per week (Almario et al., 2018). Additionally, GI disturbances are some of the most 
common and burdensome reasons for visits to primary and tertiary care offices, and digestive 
diseases account for 100 million ambulatory care visits annually (Almario et al., 2018). The most 
prevalent symptoms in clinical settings include heartburn/reflux (31%), abdominal pain (25%), 
bloating (21%), diarrhea (20%), and constipation (20%) (Almario et al., 2018). As such, there 
has been an increase in recognition of the brain-gut connection and the importance of addressing 
the highly frequent comorbidities of anxiety, depression, and GI difficulties across many clinical 
settings. For example, a previous study estimated 27% of female patients with irritable bowel 
syndrome (IBS) have an anxiety disorder and 32% had a depressive disorder (Banerjee et al., 
2017). In addition, IBS patients frequently report high levels of caffeine, alcohol, nicotine use, 
stress, depression, anxiety, and poor sleep habits (Canavan et al., 2014). Although IBS is not a 
psychological disorder, psychological resources that help reduce chronic stress positively 
influences IBS symptom experiences (Breit et al., 2018). The psychological mechanisms of 
action may involve activation of the Parasympathetic Nervous System (PNS) through the vagus 
nerve (Bonaz et al., 2018). Vagal tone is associated with the regulation of the stress response, 
making it a possible modulator to help treatment of gastrointestinal and psychological disorders. 
It is hypothesized the activation of the PNS through breathing techniques, meditation, and yoga 





quality of life (QOL) variables in those with clinical or non-clinical GI symptoms may have a 
significant impact on symptoms and functioning. Since the empirical recognition of the Gut-
Brain connection, there has been a new emerging field called psychogastroenterology (van 
Tilburg, 2020). This field is devoted to addressing the complex gut-brain connection, to fill in 
empirical gaps, and to provide clinical and empirical recommendations for clinical health 
psychologists.  
The discussion of IBS is an important one, because it was not until the formation of the 
Rome Criteria that researchers and clinicians were able to fully classify on a symptom dimension 
the experience of those with IBS. This was a breakthrough because until then, IBS patients were 
a unique subset of gastroenterological patients. This was because their self-reported symptoms 
did not have direct biological correlates, anatomical features, or a structural basis for diagnosis.  
Up until 2016, these disorders were called Functional Gastrointestinal Disorders (FGIDs). The 
term “functional” is now being phased out, and these group of disorders have been renamed as 
disorders of gut-brain interaction or DGBI  (Schmulson & Drossman, 2017). Utilizing the Rome 
process to classify and legitimize the experience of IBS patients revolutionized our 
conceptualization of symptom interpretation in psychogastroenterology.  The rationale for a 
symptom-based classification allowed for IBS to be diagnosed based off symptom groupings, 
which are most often what patients are verbally reporting to their physicians. Since then, the 
Rome process has evolved and received several iterations. Currently the field is on Rome IV. 
The Rome IV criteria includes a diagnostic taxonomy containing 6 primary domains for adults. 
These include 1.) esophageal disorders, 2.) gastroduodenal disorders, 3.) bowel disorders, 4.)  
centrally mediated disorders of GI pain, 5.) gallbladder and sphincter of Oddi disorders, and 6.) 





severity. The domain relevant to this study are 3.) bowel disorders (Lacy & Patel, 2017). Bowel 
disorders are separated into 6 subcategories including an IBS subcategory, the most frequently 
diagnosed GI disorder. Recently, applying the Rome IV criteria to DGBI has received some 
criticism. Lacy et al. (2016) suggests that DGBI should be conceptualized as a “…spectrum of 
chronic GI disorders with combinations of symptoms existing on a continuum rather than as 
discrete disorders.” (Lacy et al., 2016) Additionally, neuro-gastroenterology has shifted to adhere 
to a biopsychosocial model for their understanding of these disorders: “…without a structural 
basis to explain its clinical features, our understanding of these disorders adhere to a 
biopsychosocial model.” (Drossman & Hasler, 2016) Further research investigating the existence 
of these disorders on a continuum is a necessary step for the progression of the field of 
psychogastroenterology.   
Abnormal GI Symptomatology 
It is important to extend the discussion of classifying DGBI to include our understanding 
of abnormal GI symptomatology. What is an abnormal GI experience? How do we better 
understand and define not only specific symptoms that comprise our gastrointestinal functioning, 
but what is the threshold for normality vs. abnormality? Could GI experiences be better captured 
on a continuum? 
DGBI are disorders defined by a combination of both “…chronic and recurrent 
gastrointestinal symptoms that are not explained by structural or biochemical abnormalities.” 
(Delvaux, 2003) The original conceptualization of DGBI viewed these disorders as 
psychosomatic. Within this framework, psychological complaints and attention seeking behavior 





excessive gas, bloating of the abdominal region, indigestion, and abdominal discomfort (Collins, 
2007; Lea & Whorwell, 2004). Now, IBS and its symptom features are considered as 
multifactorial, with psychological influences considered to be just one element of symptom 
expression.  
Since DGBI symptoms are non-specific and exist in the absence of any biomarkers, IBS 
consists of a significant portion of these disorders. The etiology of IBS is unknown and is 
accompanied by diarrhea, constipation (or alternating between both), and abdominal pain 
(Collins, 2007; Delvaux, 2003). This syndrome can be episodic or continuous, and patients 
report their symptoms persist over several years (Sperber et al., 2017). In the US, IBS affects 10-
15% of adults and account for 20-50% referrals to specialty gastroenterology clinics (Hulisz, 
2004). Onset of IBS symptoms typically occur during adolescence years, and occur in those 
between the ages of 15-65 (Quigley et al., 2016). Community based studies on IBS prevalence 
reveal considerable heterogeneity across studies. In a recent epidemiological study, 41 countries 
and 83 papers were investigating IBS prevalence across the globe. Results indicated a significant 
degree of heterogeneity of IBS prevalence across the globe and a single pooled global prevalence 
rate of IBS remains elusive. For example, some countries had a rate of 1.1% of IBS, where 
others had 35.5% prevalence rate (Sperber et al., 2017).  
Using the Rome IV classification system, IBS diagnostic criteria is defined as 
experiencing recurrent abdominal pain on average at least 1 day per week in the last 3 months. 
This abdominal pain must be associated with at least two or more of the following criteria 1.) 
related to defecation, 2.) associated with a change in frequency of stool, and 3.) associated with  
a change in the appearance of stool (Lacy & Patel, 2017). Other pain thresholds are set for 





abdomen). Pain thresholds and frequencies also differ on biological sex. In one of the largest 
studies surveying 71,000 Americans, 65% of females endorsed experienced at least one GI 
symptom in the past week, compared to 56.9% of males (Almario et al., 2018). This study also 
found that those that are female, of younger age, are non-Hispanic white race/ethnicity, have a 
higher educational level and other medical comorbidities are significantly more likely to 
experience co-occurring GI symptoms (Almario et al., 2018). GI symptom prevalence 
differences between men and women may be attributed to menses. Menses may increase the 
likelihood that a female endorses belly pain, bloating/gas, nausea, or altered bowel habits (in the 
form of diarrhea). An exploratory study found that experiencing one or more GI symptoms 
before and during menses was very common in a healthy cohort of females (Bernstein et al., 
2014).  In fact, 70% of their sample endorsed experiencing GI symptoms in conjunction with 
their menstrual cycle (Bernstein et al., 2014).  
Population: Emerging Adults 
The time period between adolescence and full adulthood occurs between the age of 18 
and 25. This crucial time period is termed emerging adulthood (Arnett, 2000). Emerging 
adulthood can be marked by instability, social and geographical changes, a shift from 
dependence to independence, and a change from pediatric to adult healthcare utilization. 
Epidemiological research has established emerging adults are at an increased risk for a host of 
psychological problems and transitional difficulties. These changes create uncertainty, which 
place demands on the individual’s coping skills and may precipitate depressive episodes or lead 
to an exacerbation of existing depressive symptomatology. Specifically, the National Institute of 





among individuals in this period as compared with other age groups. According to Mojtabai et al. 
(2016), between 2005 and 2014, 12-month major depressive episodes in young adults increased 
from 8.8% to 9.6% (Mojtabai et al., 2016). Furthermore, the National Institute of Mental Health 
(2017) and results of the National Comorbidity Study Replication (NCS-R) by Harvard Medical 
School reported that anxiety disorder prevalence was 22.3% for individuals ages 18-29. 
Additionally, those between the age of 18-25 experienced the highest prevalence rate for any 
mental illness, as described by emotional, behavioral, or mental disorders (Kessler et al., 2005; 
Mojtabai et al., 2016). Research has indicated pediatric patients with IBS that transition into 
adult healthcare “… demonstrate disease-related complications, poor self-management, 
worsening disease complications, and low adherence to medications.” (Trivedi & Keefer, 2015) 
Emerging adults represent a unique subset of the population, as at first glance, they 
appear to be a relatively physically healthy cohort. However, recent epidemiological research has 
suggested that incidence rates of DGBI in emerging adults are on the rise. A recent study 
(Almario et al., 2018) investigated 12,419 emerging adults and found reported GI symptoms 
were prevalent. In the study, 54.6% of the sample endorsed one or more GI symptom in the past 
week, as measured by the NIH GI-PROMIS® scales (Almario et al., 2018). Previous research 
conducted in the Health Psychology Lab (Vivier et al., 2020) found in an emerging adult sample, 
25.8% reported experiencing at least one moderately severe GI symptom, such as gas or bloating 
or belly pain. Another Health Psychology Lab study found that 38.1% of an emerging adult 
sample reported experiencing moderate to severe anxiety, 33% reported mild depressive 
symptoms, and 21.2% reported experiencing moderate to severe depressive symptoms (Ross et 





relationship between anxiety symptoms and health-related quality of life (HRQoL), and partially 
mediated the relationship between depressive symptoms and HRQoL (Ross et al., 2020). 
Gastrointestinal and psychological complaints have the potential of impacting multiple 
domains of life. There has been an increase in academic and clinical work to acknowledge the 
interplay of these variables. However, few studies have investigated these relationships specific 
to the developmental period of emerging adulthood. As such, investigating an emerging adult 
sample has several advantages over other subgroups of the population. As this cohort of the adult 
population represents a non-clinical sample, it allows for testing theory-based hypotheses. This 
research can also provide further evidence that incidence rates of DGBI are increasing in this 
subset of the adult population.  
Consideration of Relevant Issues of Diversity  
The perception of a symptom may determine if it is viewed as an aberrant process, 
illness, or an indicator of a disease. Factors that contribute to symptoms perceptions include the 
population, cultural group, and values of an individual. For example, one population may 
perceive a symptom as problematic, and another may not. Additional influences may include 
societal and cultural values, individual temperament variances, and as noted previously, 
biological sex. Indeed, cultural influences have been found to have an impact on symptom 
presentation and healthcare seeking behavior in DGBI (Chuah & Mahadeva, 2018). One major 
shift in Rome IV was addressing previous multicultural limitations by moving from a Western 
ethnocentric focus to adapting a multicultural orientation. This orientation focuses on 
conceptualizing DGBI and culture in relation to the patient, physician, food and eating, symptom 





illness explanatory models (Dinos et al., 2017). Illness explanatory models are symptoms or 
disease related beliefs that affect concerns and expectations related to healthcare (Dinos et al., 
2017). Symptom reporting is an additional factor to consider, and this is especially apparent with 
translation across different languages. Due to this, Rome II removed the term “discomfort” to 
“pain” in Rome IV. Additionally, the term “bloating” poses issues in translatability (in Spanish 
and Italian languages;(Schmulson & Drossman, 2017). Pictograms may need be designed and 
validated in cross-cultural work. Additionally, effective and efficient recruitment of diverse 
populations is lacking. The effects of socioeconomic status have not been well described in 
previous studies.  
Studies investigating cultural factors postulate that language, symptom perception and 
cultural habits strongly influence disease presentation in Eastern cultures compared to Western 
cultures (Francisconi et al., 2016). Studies also find that Eastern and Western cultures differ 
greatly on occurrence of abdominal pain and bloating frequency in those with IBS.  For example, 
Hong Kong IBS studies report 32% of those with IBS report abdominal pain, and 68% report 
bloating. Chinese based studies report 58% abdominal pain and 64% bloating in IBS patients, 
compared to European studies that report 88% abdominal pain and 80% bloating rates. In the 
United States, prevalence studies report 100% abdominal pain frequency in irritable bowel 
studies and 83% bloating (Sperber et al., 2020). IBS appears to be more frequently reported in 
females, those of younger ages, and non-Hispanic White race ethnicities (Almario et al., 2018; 
Herman et al., 2010). Respondents that identify as Black and Asian are 31% and 35% less likely, 
respectively, to have experienced GI symptoms within the past week compared to those that 
identify as non-Hispanic White. Respondents that identify as Black, Asian, and Hispanic have 





Asian-American, Black, or Native American are more likely to endorse significantly impaired 
HRQoL despite lower prevalence rates of IBS (Chuah & Mahadeva, 2018). Further, cultural 
preferences for traditional remedies and variation in healthcare systems may lead to different 
healthcare seeking behavior in Asian patients. It is unclear if these findings reflect lower 
symptom burden or are attributed to cultural factors (Chuah & Mahadeva, 2018). Cultural status 
also may influence verbal report in medical settings. For example, a patient of Asian descent 
may be more likely to report physical symptoms rather than psychological symptoms (Chang et 
al., 2006; Herman et al., 2010; Sperber et al., 2020; Sperber et al., 2017; Brennan MR Spiegel et 
al., 2014).   
GI Health: A Latent Construct  
Prior to the formation of the Rome classification system, there was limited recognition or 
understanding of symptoms or associated behaviors in the absence of pathology. The difficulty 
of capturing prevalence rates of IBS and setting pain threshold criterion suggests an important 
point; could symptom dimensions or groupings be better classified as one underlying construct 
of GI health? 
Recent cross-sectional evidence has suggested that an underlying construct of GI health 
can be created using the NIH PROMIS® scales (Ross et al., 2020). The NIH PROMIS® includes 
six symptom scales to assess for gastrointestinal functioning. Initially, a measurement model was 
tested to create a higher-order construct of GI health using the PROMIS® GI symptom scales. 
Latent GI health was estimated from the six symptom scales to assess for gas and bloating, 
reflux, constipation, diarrhea, nausea and vomiting and belly pain (B. M. Spiegel et al., 2014). 





.001, CFI = .96, RMSEA = .08, (90% CI .07, .10), SRMR = .03. This preliminary finding 
supports the use of creating a higher-order construct of GI health using the six PROMIS® GI 
symptom scales. The benefit of using a higher-order construct of GI health is to capture 
individuals who may exhibit multiple GI symptoms across several symptom domains. This is 
supported in recent research investigating the classification of GI symptoms in emerging adults 
(Vivier et al., 2020). This study found that symptoms of bowel disorders occur on a continuum 
of severity across fluctuating symptom areas. When applying a categorical approach, the mild 
and moderate symptom groups fit most closely to IBS mixed or unclassified subtypes. Findings 
concluded that this subset of the population do not fit neatly in a symptom classification and 
supports a dimensional approach to assesses for gastrointestinal functioning. These findings 
corroborated previous studies of DGBI (Chey et al., 2015; Lacy et al., 2016; Simren et al., 2017; 
Whitehead et al., 2002). 
Biopsychosocial Model and GI Health 
 The biopsychosocial model offers a framework for understanding the interconnected 
relationship between biological functioning (i.e., GI health), social, and psychosocial processes. 
Those with quality of life and psychological consequences due to their gastrointestinal symptoms 
should not be viewed as less legitimate as those that carry a gastrointestinal diagnosis.  
Gastrointestinal health has the potential to be an important avenue for general psychological 
functioning and quality of life. Its associated features will be the topic of the next section.   
Gut Brain Connection and Hypothesized Directionality 
The directionality of psychological distress and GI symptoms is still relatively 





distress and GI symptoms are bidirectional in nature. Previous research has attempted to identify 
the correct temporal order between psychological disorders and DGBI. That is, do psychological 
symptoms precede having a GI condition? Or, in contrast, does a GI condition precede a 
psychological condition? In a study investigating a community setting to examine these 
associations, researchers found experiencing a simultaneous diagnosis of a GI and psychological 
condition were observed in 5% of individuals, 61% of the sample experienced a psychological 
condition that preceded their GI condition, and GI conditions were observed first in 34% of 
individuals (Jones et al., 2017). Other prospective studies have elucidated in an estimated 50% of 
IBS cases, gastrointestinal symptoms emerged first, followed by mood disorders (Koloski et al., 
2016; Koloski et al., 2012). Another study investigating incidence rates for mood, anxiety, and 
IBS found 40% of mood disorders and 23% of anxiety disorders followed the onset of IBS 
(Sykes et al., 2003). Other findings have suggested psychological distress may often precede GI 
symptoms and a DGBI diagnosis (Jones et al., 2012). Other researchers have postulated the brain 
drives IBS symptoms (conceptualizing IBS as a brain or somatic symptom disorder; (Patel et al., 
2015). Nonetheless, these findings are supportive of the bidirectional hypothesis suggested by 
the biopsychosocial model (Jones et al., 2017). This research also supports the heterogeneous 
nature of DGBI in terms of its reciprocal association with psychological symptoms. 
Psychological Distress: A Risk Factor for Disorders of Gut-Brain Interaction 
 The gut-brain connection explains why stress and psychological factors are so closely 
linked to gut function and dysfunction, gastrointestinal symptoms, illness, and disease 
(Drossman, 2014). Social stressors have been shown to make DGBI refractory to treatment. Not 





psychological conditions, and higher reported stress levels. Often, those in higher education are 
undergoing higher levels of social, academic, and socioeconomic stressors. Previous research has 
indicated IBS-like symptoms are highly prevalent in those enrolled in undergraduate and 
graduate level education. In an international survey, 34% of undergraduate students, 41% of non-
medical graduate students, and 26% of medical graduate students endorse having IBS (Jafri et 
al., 2005; Qureshi et al., 2016). Some researchers have even posited IBS symptoms are a global 
challenge for those enrolled in university (Chen & Ye, 2020). Addressing psychosocial factors 
are clinically significant, particularly in emerging adults (Chen & Ye, 2020; Lea & Whorwell, 
2004). 
Historically, stress has been a fascinating and complicated area of research across many 
disciplines of psychology. Stress is an ambiguous construct and there is not one entirely agreed 
upon definition. Humans are constantly changing organisms that function and adapt in 
accordance with their environment. Any influence, adjustment, or adaptation on one’s 
homeostasis can be considered a stressor (Selye, 2013). Stress can be biological, social, and be 
perceived as desirable or undesirable. The most notable aspect of stress is a person’s 
interpretation of the event. This interpretation of whether an individual perceives a stimulus or 
life event as stressful can depend on a multitude of factors. This includes one’s coping 
mechanisms, personality, culture, biology, attitudes, and previous experience with similar events 
(Lazarus, 2006). Most healthy individuals that carry no GI diagnosis often experience abdominal 
discomfort and changes in their bowels when they experience psychological distress. This 
phenomenon underlies the observational relationship between GI function and an individual’s 
psychological state (Drossman, 2014). Furthermore, psychological distress may play a pivotal 





sensitive disorder (Qin et al., 2014). Previous research has indicated stress directly effects 
intestinal motility (stretching and contracting within the GI tract), permeability (substances 
passing through the intestinal wall), the gut microbiota composition, and visceral 
hypersensitivity (decreased threshold for pain in the abdomen in response to pressure or 
stimulation;(Chong et al., 2019; Zhou & Verne, 2011; Zhuang et al., 2017). It has been 
postulated the mechanisms of action for stress on the GBA include the activation of the HPA 
axis by the release of inflammatory cytokines, corticotrophin releasing factor (CRF), 
adrenocorticotropic hormone, and cortisol (Chong et al., 2019; Dinan et al., 2006). In turn, these 
effect the balance of the GBA and homeostasis of the gut. Clinically, there is an imperative to 
teach patients with gastrointestinal complaints to manage levels of psychological distress as apart 
of existing evidence-based therapies.  The field devoted to these pursuits is called 
psychogastroenterology (van Tilburg, 2020). 
Psychological Distress: A Latent Construct  
The multifaceted nature of one’s psychological health supports measuring an underlying 
construct of psychological distress rather than depression and anxiety separately. This conclusion 
is due to the inconsistent nature of self-report measures to reliability differentiate between the 
two constructs of depression and anxiety in factor analytic studies. Although conceptually 
depression and anxiety are distinct clinical psychological constructs, many commonly used 
measures do not reliability distinguish symptoms and clinical features of these disorders. One 
recent study proposed combining the Patient Health Questionnaire (PHQ-9) and Generalized 
Anxiety Disorder Scale (GAD-7) scales in a bifactorial model as a composite measure of 





(CFA) to create a bifactor model using a composite general distress factor with all 16 items from 
both the PHQ-9 and GAD-7. The distress factor demonstrated good fit (χ2 = 96.1, p = .26, 
CFI = .99; TLI = .99; RMSEA = .02). Additionally, the general distress measure accounted for 
84% of the explained variance in the patient sample. Results indicated that by combining the 
PHQ-9 and GAD-7  items, one can create a psychometrically valid latent construct of general 
Psychological distress (Teymoori et al., 2020). This psychometric evidence also extends to other 
self-report measures, such as the Hospital Anxiety and Depression Scale (HADS). A systematic 
review of 50 latent variable analyses conducted on the HADS revealed it is unable to 
consistently differentiate between the constructs of anxiety and depression. The review 
recommends its use as a general measurement of distress (Cosco et al., 2012). Clinically, anxiety 
and depression may share many of the same symptom features such as fatigue, difficulty 
concentrating, irritability, and sleep disturbances. An ideographic review of individual test items 
on these scales has clinical value. For example, on a depression scale, gathering information 
related to suicidal or homicidal risk. Nonetheless, the nomothetic value of these scales remains to 
be consistently supported empirically. As supported by previous factorial and latent structure 
studies, this study used anxiety and depression measures as indicators of a higher-order latent 
construct of psychological distress. 
Disability Outcome: A Latent Construct 
Gastrointestinal symptoms have the potential of incurring significant consequences on an 
individual’s general functioning. Quality of life (QOL) or health-related quality of life (HRQoL) 
is a multi-dimensional construct including physical, emotional, and social functioning as 





correlate highly with an individual’s HRQoL (Simões et al., 2016). Those that have impairments 
in general functioning may have difficulty in the ability to fully engage in a social life, be 
dependent on others, and experience diminished individual responsibility and fulfillment of 
personal and social responsibilities. Self-report measures of disability and HRQoL are commonly 
used in research as an outcome variable. Disability and HRQoL are commonly cited and 
conceptualized as an outcome variable of the GBA. A self-report measure of disability quantifies 
an individual’s objective performance in each life domain, whereas a measure of quality of life 
(QOL) captures an individual’s subjective well-being (i.e. their satisfaction with a particular 
health domain; (Üstün, Chatterji, et al., 2010). Ultimately, these constructs are interrelated. This 
study focused on measuring disability and levels of functioning instead of QOL. This was 
because disability is operationalized as an individual’s performance in multiple life domains 
(such as self-care, communication, mobility, etc.). In contrast, quality of life is operationalized as 
an individual’s satisfaction with their life domains. Additionally, there is a paucity of research 
investigating disability in relation to gastrointestinal functioning. As such, most of the literature 
found in the latter review reviewed HRQoL or QOL. A secondary aim of this study was to 
further investigate the relationship between the construct of disability and gastrointestinal health 
in emerging adults to fill this existing empirical gap. 
In clinical populations, DGBI are associated with lower physical and mental HRQoL. 
One study surveyed 6,312 participants with co-occurring multiple sclerosis and DGBI (Marrie et 
al., 2019). Using the Rome III criteria, the prevalence of DGBI were statistically significantly 
associated with increasing greater disability, and lower physical and mental HRQoL (Marrie et 
al., 2019). In an internet-based survey, including US, Canada, and UK respondents, a study 





cumulative effect on HRQoL outcomes (Aziz et al., 2017). 6,300 representative participants of 
the general population were surveyed, and they found 35% of participants had a DGBI in 
comparison to a non-GI diagnosis and organic GI-disease controls. Of note, the presence of 
DGBI also had increasing somatic symptoms, worsening mental and physical QOL, and greater 
healthcare utilization. Most interestingly was the finding that “…individuals with DGBI had 
worse somatization and QOL scores than organic-GI disease controls.” (Aziz et al., 2017) 
Further, DGBI represent the bulk of gastroenterology outpatient visits, and account for 
12% of primary care visits. The burden of gastrointestinal symptoms on the healthcare system is 
significant. IBS symptoms are associated with an estimated 2.2 million prescriptions and 
estimated 8 billion of medical costs (Qureshi et al., 2016).  
These findings, among others, suggest that there are significant unmet needs and burdens 
placed on those with deleterious gastrointestinal functioning, such as their work productivity and 
social functioning (Buono et al., 2017). The advantage of using a disability measure as an 
outcome is its breadth of covering the multi-dimensional nature of functioning. These domains 
may include difficulty understanding and communicating, getting around, self-care, getting along 
with people, life activities (household and/or schoolwork), and participating in society. The 
World Health Organization (WHO) originally created the WHO Disability Assessment Schedule 
(DAS) to assess the functioning of psychiatric inpatients in 1988 using the International 
Classification of Functioning, Disability, and Health (ICF) (Üstün, Kostanjsek, et al., 2010). The 
ICF conceptualizes human functioning as a continuum of health states. ICF uses the 
biopsychosocial model to conceptualize the varying degrees of functioning within each disability 
domain. This model recognizes that disability is multidimensional, and to account for the 





classification postulates that everyone can exhibit some degree of disability at the following 
levels: 1.) body (body functioning and structure), 2.) activities (activity limitations), and 3.) 
participation (participation restrictions). Thus, they consider the body, the person, and the society 
in their aim to capture the complete existence of disability (Üstün, Chatterji, et al., 2010). The 
present study used this conceptualization and measurement for disability by using the WHODAS 
2.0, a general health and disability measure. This measure includes six domains of functioning 
that fall under the three levels mentioned above. These include self-care, cognition, mobility, 
adaptive functioning, daily living, mobility, and communication (Federici et al., 2017; Üstün, 
Kostanjsek, et al., 2010). The simple scoring approach of the WHODAS allows the sum of the 
scores across all domains to represent a statistic to describe the degree of functional limitation in 
the general population.  
Current Study 
Based on the existing scientific knowledge, the current study contributed to the growing 
literature on the interplay of GI health, psychological distress, and disability over time using the 
biopsychosocial framework. The goal of the study was to further understand the directional 
relationships between these variables among an emerging adult population. Although the gut-
brain interaction has been established, additional research on its directionality and its association 
with functioning remain to be an understudied area in this population. This study had several 
advantages over previous studies. Using a repeated-measures study design, data were collected in 
two waves; at time one (T1) and time two (T2) with one month in between data collection (4-
weeks). This study design promoted a better understanding of temporal precedence and 





disability. Secondly, data collection was from a non-patient population. The advantage of a non-
clinical sample supports analyses to investigate theory-based questions related to the gut-brain 
connection. Using these measures, construct validity was established by providing evidence of 
measurement equivalence, temporal stability, and predictive power. Error variance was 






CHAPTER THREE: STUDY HYPOTHESES 
The goal of this study was to test a biopsychosocial model of GI health, psychological 
distress, and disability in an emerging adult population using a cross-lagged panel model 
(CLPM). Cross-lagged associations between GI health, psychological distress, and disability 
were examined.  Using this methodology addressed the following study aims. 
Study Aims 
(1) Infer directional and reciprocal causation between GI health, psychological 
distress, and disability using CLPM. The CLPM was examined for the strength of 
the direct effects in the cross-lagged panel model. By choosing this method of 
analysis, direction of these relationships and consideration of potential reciprocal 
effects was conducted. 
a. Consistent with the GBA hypothesis, it was hypothesized a reciprocal gut-
brain connection would be established at T1 and T2.  It was hypothesized 
GI health would predict psychological distress and psychological distress 
would predict GI health (bidirectionality/reciprocal cross-lagged effects).  
(2) The CLPM analysis investigated the directional and reciprocal causation between 
GI health, psychological distress, disability.  
a. Does psychological distress and disability reciprocally interact over time?  
b. Can a directional causation be inferred between GI health and disability at 





Gut-Brain Reciprocal Connection Hypotheses 
It is well-established physical symptoms are strongly associated with psychological 
distress. Gastrointestinal symptoms have emerged as one of the most dominant somatic symptom 
clusters associated with distress (Patel et al., 2015; Qin et al., 2014; Simon et al., 1996; Spiegel 
et al., 2008). In chronic GI disorders, clinical recommendations emphasize evaluating a patient to 
determine “…whether patients are more gut than brain or more brain than gut in their illness 
expression.” (Spiegel et al., 2011) This clinical concept is framed “GI distress.” (Spiegel et al., 
2011) Emerging adults are particularly vulnerable to stress and other psychosocial variables. 
Higher psychological distress can lead to increased stress-response, inflammation, and arousal of 
the autonomic nervous system (Koloski et al., 2016; Lucas, 2018; Mayer et al., 2015; Won & 
Kim, 2016). These physiological mechanisms of action have the potential of leading to higher 
self-reported gastrointestinal symptoms. 
 
Hypothesis 1: GI health at Time 1 predicts psychological distress at Time 2. 
Hypothesis 2: Psychological distress at Time 1 predicts greater GI Health at Time 2. 
It was hypothesized these variables would both predict each other, i.e., they would 
demonstrate a reciprocal and bidirectional relationship over time. 
Psychological Distress and Disability Reciprocal Connection Hypothesis 
Research has consistently demonstrated psychological distress and disability (defined as 
impairments in functioning, difficulty engaging in activities of daily living, and general health) 
are highly correlated. Individuals with disabilities often experience high rates of psychological 
distress (Cree et al., 2020; Okoro et al., 2009). Additionally, major depression and anxiety 





for a diagnosis of these disorders (Association, 2013). In a global population report published by 
the World Health Organization, depression was found as the leading cause of disability 
worldwide. The report found high rates of comorbid anxiety and depressive disorders (Friedrich, 
2017). Additionally, the nature of anxiety and depression symptoms existing simultaneously 
supports this study’s empirical reason for combining anxiety and depression measures into a 
general measure of distress. Emerging adults also experience the highest prevalence rate for 
emotional, behavioral, and psychological disorders (Kessler et al., 2005; Mojtabai et al., 2016). 
According to the American College Health Association (2015), an estimated 60% of enrolled 
college students self-report they experience overwhelming anxiety. The American College 
Health Association also found 15% of emerging adults had depressive symptoms that they said 
impacted their academic performance and ability to function (Blanco et al., 2008; Pedrelli et al., 
2015). Other college-based studies have revealed one-third of undergraduate students experience 
suicidality, depression, or anxiety (Oswalt et al., 2020). Undergraduate students also exhibit high 
comorbidity rates: of undergraduate students with depression, 40% also met diagnostic criteria 
for generalized anxiety disorder (GAD) (Eisenberg et al., 2013; Oswalt et al., 2020).  Guided by 
these empirical findings, it was hypothesized there would be a reciprocal relationship between 
these latent variables across the two time points.   
Hypothesis 3: Psychological distress at Time 1 predicts disability at Time 2.  
Hypothesis 4: Disability at Time 1 predicts psychological distress Time 2.  
It was hypothesized these variables would both predict each other, i.e., they would 





GI Health and Disability Outcome Hypothesis 
Difficulty adjusting to life activities has been commonly reported in patients with DGBI. 
GI symptoms are an illness burden that may affect an emerging adult’s working life and 
academic functioning. IBS symptoms are associated with impaired work productivity, increased 
healthcare utilization, more sick days, and other psychosocial domains (Faresjo et al., 2019). 
Those with IBS indicate their GI symptoms significantly interfere with daily functioning, in that 
they cannot fully engage with social, work, and home life.  In one survey, respondents reported 
GI symptoms impacted their productivity at an average of 8 days per month and missed an 
estimated 1.5 days of work or school per month due to IBS (Ballou et al., 2019). Other data 
suggest patients with IBS are twice as likely to take time off from work, exhibit high levels of 
presenteeism (time at work unable to perform their best due to their illness), and demonstrate 
impairment in daily activities (Corsetti & Whorwell, 2017). In one study, the impact of irritable 
bowel syndrome – diarrhea (IBS-D) subtype on work productivity and engagement in daily 
activities was investigated (Buono et al., 2017). Of 66,491 respondents in the U.S. based study 
(participants aged 18 and over), those with IBS-D had significantly lower HRQoL, loss of work 
productivity, daily living impairment, and had higher indirect costs associated with their health. 
Based off these findings, it was hypothesized higher self-reported gastrointestinal symptoms 
would lead to higher impairments in functioning (self-reported disability).  
H5: GI health at Time 1 predicts disability outcome at Time 2. 
It was hypothesized a unidirectional relationship between GI health and disability would 
be established. It was hypothesized that inference of causality and temporal precedence could be 
established between these latent variables at the two time points. This was an empirically derived 





gastrointestinal disorders. Although the reciprocal relationship between mood (psychological 
variables) and GI functioning has a theoretical and biological underpinning, disability is 
conceptualized as an impairment in multiple life domains that often is a result of diminished 
functioning related to physical or psychological disorders. In other words, disability as an 
antecedent variable to GI symptoms does not have a theoretical basis. As such, a unidirectional 
pathway was expected.  
Contribution to Literature 
As discussed in the literature review, the current evidence is mixed regarding the 
temporal precedence of self-reported distress, gastrointestinal, and disability. Even more so, 
these questions have not been investigated in an emerging adult sample. Studies have tried to 
determine if GI conditions, or mood symptoms arrive first. Findings reveal high rates of 
comorbidities (IBS patients present with high levels of anxiety and depression). Alternatively, 
other studies have shown IBS symptoms are driven by the brain, suggesting mood 
symptomatology arises first, preceding GI symptom presentation. The use of a non-clinical 
sample has an advantage over clinical studies as it promotes an investigation of these theory-
based questions. A cross-lagged panel models provides a methodological approach to examine 
these reciprocal relationships over time. The presence or absence of reciprocal relationships 
suggest a direction for assessment and intervention in individuals with these psychological and 
physical symptoms. Notably, the emerging adult population are relatively understudied 
particularly in this area of gastrointestinal health (Jafri et al., 2005; Qureshi et al., 2016). This 







CHAPTER FOUR: RESEARCH DESIGN AND METHODOLOGY 
Participants 
Eligibility Criteria 
Participants met criteria to participate in the study if they were between the ages of 18 
and 25 years (emerging adults) at the University of Central Florida. Participants were 
undergraduates and enrolled in an introductory psychology course (General Psychology) and 
participated in a two-part online study for course credit. Participants were across all 
undergraduate majors at the university.  
Recruitment 
The online survey was presented on the university’s undergraduate psychology research 
participation website with a brief description of the study’s components. Students were awarded 
course credit for their participation. Participants were required to have taken the online survey at 
Time 1 to take the survey at Time 2. 
Ethical Concerns 
 The university’s Institutional Review Board determined the present study to be human 
subjects research that is exempt from regulation (See Appendix A). The university’s Institutional 
Review Board has also issued the study closure as data collection had been completed (see 
Appendix B). Informed consent was obtained from all participants that took the study survey. 
Data were all de-identified when downloaded as research personal only had access to a 





research participants but has no connection to identifying information and there is no way to link 
the ID with the student’s name. If a participant rated 1 (several days), 2 (more than half the 
days), or 3 (nearly every day) on item 9 on the PHQ9 they were directed to services. Item 9 on 
the PHQ9 asks: “Have you had thoughts that you would be better off dead or hurting yourself in 
some way?” The following resources were provided to research participants: the number for 
Counseling and Psychological Services (CAPS) at UCF, Crisis Hotline, and CAPS emergency 
resources as well as their website URL.  
Study Design and Procedures 
Recall Period 
The measures used here were available to use for research under the condition the 
instructions would not be modified. The primary measures used in this study have a different 
time window for participants to rate their functioning. In the case of the PROMIS measures, 
recall is over the past 7 days. In the case of the GAD7 and PHQ9, it is a 14-day period. The 
WHODAS requires a 30-day recall. The influence of recall period on self-report has been studied 
empirically. Several studies have found no significant effects based on the length of recall 
(Batterham et al., 2019; Condon et al., 2020; Lai et al., 2009). In one recent PROMIS study, 
recall periods were compared across three conditions: no recall, 24- hours, or 7- days with the 
PROMIS Physical Function Scale (Condon et al., 2020). According to the findings of the study, 






Data were collected via an online survey over the course of five semesters at the 
University of Central Florida. This study uses a repeated measures study design. A repeated 
measures design refers to collecting multiple measures of the same variable taken on the same 
subjects either under different conditions or over two or more time periods. Data were collected 
at time one (T1) and time two (T2) with one month in between data collection (4-weeks). Data 
collection began during the Spring 2019 semester. Within each semester, research participants 
took part in a two-part survey. The online survey had a total of 140 questions and took 
approximately 30 minutes to complete. The same online survey questions were repeated at each 
time point. See Measures section for description of measures. 
Study Setting 
The study was conducted via an online format within the University of Central Florida’s 
undergraduate research participation system. The website allows potential research participants 
to peruse available online studies at the University of Central Florida. The website provides 
participants with a brief description of the study and the amount of course credit they will receive 
for participating. The undergraduate research participation system is synced with Qualtrics, an 
online survey website for data collection. The research participant is then awarded course credit 







Demographic characteristics included age, biological sex, racial or ethnic identification, 
marital status, classification in college, housing, physiological profile including weight, height, 
and smoking status. The survey also included a question if the research participant carries a 
diagnosis of diabetes, IBS, Celiac Disease, or does not know. The survey contained an item for 
female research participants to rate the degree to which any gastrointestinal symptoms they 
reported are related to their menstrual cycle. This item is presented on a Likert scale of 0 (not at 
all) to 4 (very much). Lastly, a medical services question inquired on a yes/no basis if the 
participant had sought out medical treatment for their gastrointestinal health over the last six 
months.    
Validity Check Items  
Nine items were dispersed randomly throughout the survey to identify participants that 
had random, careless, or had inattentive responding. Example items include: “For this item, 
please select Yes,” and “For this item, please select Never.” Participants were excluded from the 
sample if they answered one or more of these questions incorrectly. This approach has been used 
successfully in the Health Psychology laboratory. The use of VCheck items is recommended for 






NIH PROMIS  
The National Institute of Health has developed the Patient-Reported Outcomes 
Measurement Information System (PROMIS). The PROMIS is a standardized set of patient-
reported outcomes that assess for multiple domains of health, including physical, psychological, 
and social health. The PROMIS  can be used in both clinical populations and in the general 
population (B. Spiegel et al., 2014). All PROMIS measures in the present study were scored via 
the Health Measures Scoring Service, powered by Assessment Center℠. As recommended by 
the creators, T scores were used for analyses and interpretation. A T score is a standardized score 
that is based on a normal curve where a T score equivalent to 50 is an average score of a 
comparison or norm group.  
NIH PROMIS Emotional Distress- Depression- Short Form 8a 
 This instrument is a fixed length short form that assesses for depressive symptoms 
in the past 7 days. These items inquire about symptoms such as feeling worthless, helpless, 
depressed, hopeless, like a failure, and unhappiness over the past seven days.  The instrument 
contains eight items on a 5-point Likert scale ranging from 1 (Never), to 5 (always). A T score 
was used for analyses and interpretation. A T score is a standardized score that is based on a 
normal curve where a T score equivalent to 50 is an average score of a comparison or norm 
group.  Reliability analysis was run (Cronbach’s alpha) for the NIH PROMIS Emotional 
Distress-Depression. Acceptable internal consistency was found at both Time 1 (α = 0.95) and 





NIH PROMIS Emotional Distress-Anxiety Short Form – 8a.  
The NIH PROMIS Anxiety-8a was designed as a fixed length short form to assess for 
anxiety and fear in an adult population. This instrument contains eight items on a Likert scale 
ranging from 1(Never) to 5 (Always).  The eight items ask a respondent the degree they would 
endorse symptoms such as feeling tense, anxious, nervous, uneasy, worried, fearful, and having 
difficulty focusing. A T score was used for analyses and interpretation. A T score is a 
standardized score that is based on a normal curve where a T score equivalent to 50 is an average 
score of a comparison or norm group.  Reliability analysis was run (Cronbach’s alpha) for the 
NIH PROMIS Emotional Distress-Anxiety. Acceptable internal consistency was found at both 
Time 1 (α = 0.96) and Time 2 (α = 0.97).  
 
Patient Health Questionnaire 9 Scale 
The Patient Health Questionnaire (PHQ-9) is a nine-item, self-report scale utilized to 
screen for depressive symptoms over the past two weeks (Kroenke & Spitzer, 2002). Participants 
rate each item on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The 
PHQ-9 has demonstrated good internal consistency, test-retest reliability, criterion validity, and 
construct validity across diverse racial ethnic groups, college populations, and primary care 
studies in previous psychometric studies. Scores of 0-4 are considered minimal depressive 
symptoms, scores of 5-9 are considered mild depressive symptoms, scores of 10-14 are 
considered moderate depressive symptoms, scores of 15-19 are considered moderately severe 
depressive symptoms, and scores of 20-27 are considered severe depressive symptoms 
(Eisenberg et al., 2011; Huang et al., 2006; Kroenke & Spitzer, 2002). Reliability analysis was 
run (Cronbach’s alpha) for the PHQ-9. Acceptable internal consistency was found at both Time 1 





Generalized Anxiety Disorder 7 Scale   
The GAD-7 scale is utilized to assess for cognitive symptoms of anxiety (Spitzer et al., 
2006). Each item asks participants to indicate the frequency with which they have experienced a 
symptom during the past two weeks on a 4-point Likert scale ranging from 0 (not at all) to 3 
(nearly every day). Research has indicated the internal consistency of the GAD-7 is excellent (α 
= .92), and the test-retest reliability is good. Scores of 0-4 suggest minimal anxious symptoms, 
scores of 5-9 suggest mild anxious symptoms, scores of 10-15 suggest moderate anxious 
symptoms, and scores of 15-21 indicate severe anxious symptoms (Spitzer et al., 2006). 
Reliability analysis was run (Cronbach’s alpha) for the GAD-7. Acceptable internal consistency 
was found at both Time 1 (α = 0.93) and Time 2 (α = 0.93).   
Higher-Order Psychological Distress Factor 
A higher-order factor of psychological distress was created by using these four self-report 
measures as indicators. Regarding the PHQ-9 and GAD-7, the summary scores were used as 
indicators. T scores for the PROMIS measures were used as indicators. Taken together, these 
four indicators (two anxiety measures, two depression measures) were used to create the higher-
order latent construct of psychological distress. This was guided by several previous studies who 
have created a latent construct labeled “distress” using indicators of both anxiety and depression 
(Cosco et al., 2012; Teymoori et al., 2020; Wright et al., 2013). Although the chosen anxiety and 
depression measures in this study have item content overlap, a visual inspection of these 
measures show the PROMIS measures consistently inquire about cognitive symptoms, where 
the PHQ9 and GAD7 also inquire about somatic symptoms. The additional anxiety and 





symptoms of these disorders.  Additionally, the additional measures also allowed for a more 
robust and reliable factor.  
GI Health 
PROMIS-GI  
The PROMIS-GI  was developed to assess specific GI symptoms in six symptom 
domains. These include gas and bloating, reflux, constipation, diarrhea, nausea and vomiting, 
and belly pain separately (B. M. Spiegel et al., 2014). Research has indicated the symptom scales 
demonstrate good construct validity in the general population and diverse gastrointestinal 
patients. These symptom scales have been developed for both clinical practice and research (B. 
M. R. Spiegel et al., 2014).  As recommended by the creators of the PROMIS-GI , the present 
study used the recommended T-scores for analyses (Broderick et al., 2013; Brennan MR Spiegel 
et al., 2014). Reliability analysis was run (Cronbach’s alpha) for the PROMIS-GI . Acceptable 
internal consistency was found at both Time 1 (α = 0.83) and Time 2 (α = 0.86).  As supported in 
previous work by the author, this study combined these six symptom scales into a general latent 
construct titled GI health.  
Disability and Functioning Outcome  
World Health Organization Disability Assessment Schedule 2.0  
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a 36-
item measure designed to assess for multiple domains of disability and functioning. Disability 
was conceptualized as an outcome variable of the GBA. The WHODAS asks in the last month, 





The Likert scale scores are assigned to each item as none (1), mild (2), moderate (3), severe (4), 
and extreme (5). The six domains of functioning include: cognition (6 items), mobility (5 items), 
self-care (4 items), getting along with people (5 items), life activities (8 items), and participating 
in society (8 items). It is applicable in clinical, community, and general populations. The 
WHODAS was designed to assess activity and participation restrictions, irrespective of a 
medical diagnosis. Domain specific functioning scores were computed using the simple scoring 
approach. This approach is done by summing the scores within each of the domain using the 
scores assigned to each of the items: None is assigned a 1, Mild is assigned a 2, Moderate is 
assigned a 3, Severe is assigned a 4, and Extreme or Cannot Do is assigned a 5. There is no 
weighting of individual items. An overall summary functioning score is computed by summing 
the six domain scores. This general disability score total is out of 180. The WHODAS manual 
suggests the simple sum of the items across all domains represents a statistic adequate to 
describe the degree of functional limitations. The DSM-5 recommends this scoring approach to 
be used in busy clinical settings, such as student health services that may wish to replicate the 
findings in this study. As such, it was appropriate to utilize the simple scoring approach for an 
emerging adult population for this intended practical use. The psychometric properties 
(unidimensionality) as well as the high internal consistency allows for simple sum of scores in 
this way.  Higher scores indicate a greater degree of disability. The WHODAS has been found to 
be reliable and has a robust factor structure across cultures and different types of populations 
(Üstün et al., 2001; Üstün, Kostanjsek, et al., 2010). Reliability analysis was run (Cronbach’s 
alpha) for the WHODAS. Acceptable internal consistency was found at both Time 1 (α = 0.87) 





confirming the six subdomains loading on a general disability factor. A general disability factor 
was created by using the six domain subscale scores as indicators. 
Statistical Analyses 
Data Preparation  
Data were accumulated across five academic semesters Spring - Summer (2019), Fall 
(2019) -Spring (2020), and Summer (2020). All respondents who failed the VCheck items in 
both Time 1 and Time 2 were removed. This was to eliminate respondents with inconsistent 
responses. A deidentified participant ID was used to match those that completed the repeated 
measures on Time 1 and Time 2. 142 participants completed Spring - Summer (2019), and 22 
participants were removed for a N of 120 participants. 675 participants completed Fall 2019 - 
Spring 2020 repeated measures, and 96 participants were removed for a N of 579 participants. 
190 participants completed Summer 2020 repeated measures, and 28 participants were removed 
for a N of 162 participants. The completed dataset was then combined across the five semesters 
for a total N of 861. 
Missing Data 
Data were reviewed for missing data. A Qualtrics validation option was used to alert 
respondents about questions they may have missed during the online survey. The type of 
validation used in all questions in this study was called “forced response.” This option requires 
the respondent to answer questions before they can continue the survey, preventing them from 
going to the next page, and prompts them if their survey contains missing items. Thus, the 





respondent does not rate experiencing any GI symptoms in a symptom subscale, they will not be 
shown the consecutive item and will be skipped to the next item in the following symptom 
subscale. Thus, these items were recoded as system-missing (-999) in SPSS so that Mplus can 
recognize these items (Muthén & Muthén, 2018).  
Multivariate Normality 
Prior to analyses, all variables of interest were examined using SPSS Version 26. Testing 
the normality assumption in the sample was conducted by examining the skewness and kurtosis 
coefficients. Recommendations for acceptable values of skewness and kurtosis values vary and 
there is not one single statistic that captures all components of multivariate normality. 
Considering this, recommendations from several sources were used (Kline, 2015; Looney, 1995; 
Park & Schutz, 2005). For larger sample sizes (above 300) and for utilizing SEM methodology, 
values between − 3 and + 3 are acceptable for skewness. Kurtosis values are deemed acceptable 
if they are between the range of − 10 to + 10. However,  some researchers recommend using -7 
to +7 for kurtosis (Kim, 2013).  As SEM is a robust analytical method and this study has a larger 
sample size, small deviations may not represent major violations of assumptions. As such, 
skewness values between -3 and +3 and kurtosis values between -10 and +10 were deemed 
acceptable for the sample size (N = 861) and chosen statistical analysis (SEM).  
The distribution for PROMIS-GI subscales were normal with acceptable skewness and 
kurtosis values both at Time 1 and Time 2. Values ranged for the symptom subscales were (.05 - 
1.5) for skewness and for kurtosis values ranged from (-.7 – 1.60). These values were deemed 
acceptable and fell well within the acceptable skewness and kurtosis range suitable to conduct 





and PROMIS Distress-Depression) were normal with acceptable skewness and kurtosis values 
both at Time 1 and Time 2.  Values ranged from (0.2 – 1.30) for skewness and for kurtosis 
values ranged from (-0.4 – 1.60). Finally, the WHODAS subscales were also evaluated at Time 1 
and Time 2.  The distribution for the six WHODAS subscales scores were normal with 
acceptable skewness (values ranging from .9- 2.50) and kurtosis values (0.5-6.99). It was 
concluded that the variables reflected a distribution suitable for SEM analytic techniques.  
Data Analysis Procedure 
Descriptive Statistics  
Descriptive statistics and demographic analyses were conducted using SPSS Version 26. 
Structural equation modeling analyses were conducted using MPlus8 Version 1.6.  
Structural Equation Modeling 
This study utilized a cross-lagged panel model (CLPM). Panel models in SEM postulate 
directional and regression relationships among repeated measures. A CLPM is a type of 
structural equation model that is used where two or more variables are measured at two or more 
occasions. This type of analysis is conducted when the study’s interest is on the associations 
(often causal theories) with the variables over time. For example, a CLPM is often used when a 
study is seeking to understand and infer the direction of causality. CLPM is suitable for a non-
experimental study where variables are recorded but not manipulated (Selig & Little, 2012). 
Importantly, these statistical techniques are useful to infer causal predominance and to describe 
reciprocal relationships between two or more variables (Kearney, 2017). “Crossed” refers to 
estimating relationships from one variable to another, and “lagged” refers to the estimation of 





addition, a CLPM can account for multiple-item indicators for each construct defined in the 
model. This is accomplished by initially establishing measurement invariance over time. The 
primary goal of this type of analysis is to understand how variables influence each other over 
time and the directional influence variables may have on each other (Hamaker et al., 2015). 
Measurement Invariance Across Time  
Statistical analyses were conducted by specifying a latent variable cross-lagged panel 
model in MPlus. The first step in conducting a CLPM is to test for measurement invariance of 
our latent constructs. This CLPM was tested using the previously discussed latent constructs: GI 
health, psychological distress and disability. 
Testing for measurement invariance across time is important when using self-report 
questionnaires for underlying psychological constructs in social sciences (Van de Schoot et al., 
2012). The goal for testing for measurement invariance across time was to ensure this study was 
measuring identical constructs and the participants and underlying factors were being measured 
similarly at Time 1 and Time 2.  
Measurement invariance across time is achieved using increasingly constrained models 
(SEM) and testing if there are significant differences between each model (Van de Schoot et al., 
2012). This was accomplished by specifying a CFA and then testing the increasingly constrained 
set of models. First, a model was tested where factor loadings are equal across group, but 
intercepts can differ (metric invariance). Second, a model was run where intercepts are held 
equal, but factor loadings can differ (testing if intercepts are equal, i.e., intercept-only 
invariance). Lastly, a model was run where both the factor loadings and the intercepts were 
constrained to be equal (this tests for scalar invariance). Once this level of measurement 





were used to evaluate change in model fit after each constraint was placed on the nested models 
(i.e. Model 1- Model 3; (Cheung & Rensvold, 2002). The fit indices used were RMSEA, TFI, 
CFI, and SRMR (Cheung & Rensvold, 2002). The progress change in CFI (ΔCFI) was used as 
an indicator of comparative fit for each model. 
Cross-Lagged Panel Model   
A CLPM was conducted in MPlus using maximum likelihood estimator with robust 
standard errors. Four models (M1 – M4) were tested to investigate the relationship between the 
three constructs of GI health, psychological distress, and disability. M1 and M4 are the most 
meaningful models for interpretation as M1 tested for temporal stability and M4 included all 
reciprocal and cross-lagged paths. However, M2 and M3 results were still included in the results 
section.  
Model 1 (M1) was an autoregressive model with no cross-lagged effects, also known as a 
baseline or stability model. This model assumed the predictor of the variable at Time 1 is the 
same variable at Time 2 and demonstrated temporal stability of the variables over time.  
Model 2 (M2) was a model extending M1 that added cross-lagged paths from GI health at 
Time 1 to psychological distress at Time 2, psychological distress at Time 1 to disability at Time 
2, and GI health at Time 1 to disability at Time 2 
Model 3 (M3) was a reverse model that added reverse cross-lagged paths to M1. These 
reverse paths were: psychological distress at Time 1 to GI health at Time 2 and disability at Time 
1 to psychological distress at Time 2. The path of GI health at Time 1 to disability at Time 2 





Model 4 (M4) was a reciprocal causation model that included all autoregressive and 
cross-lagged paths from M1 to M3 (Van de Schoot et al., 2012; Vötter & Schnell, 2019). See 
Figure 1 below for the proposed CLPM that was conducted in this study.  
Cross-lagged Panel Model Stability and Cross-lagged Effects 
Finally, the previous models were examined for stability and cross-lagged effects. 
Summary fit statistics are presented for the tested four models (M1 - M4). A cross-lagged effect 
means that there is a significant effect of one variable on another variable after controlling for the 
variable’s stability over time. The final model (M4) including all reciprocal pathways was 
assessed for strength. Interpretation of Model 4 promoted a greater understanding of the latent 
variable relationships that had the greatest and more significant predictors of reciprocal causality 








Figure 1: Proposed Cross-lagged Panel Model.   
Note. Two-wave cross-lagged panel model between GI health, psychological distress, and 
disability. M1 Paths (orange lines) represent the baseline/stability model. M2 paths (black lines) 
represent the normal causation model. M3-paths (blue lines) represent the reverse causation 





















CHAPTER FIVE: DESCRIPTIVE STATISTICS RESULTS  
Sample Descriptive Statistics  
See Tables 1- 14 for descriptive statistics. Overall, the emerging adult sample represented 
a range of functioning in GI symptoms, psychological distress, and disability.  
Pearson’s Correlation Coefficients 
Pearson correlation coefficients were computed to assess the relationships between the 
variables of interest at both time points. Results of the Pearson correlations indicated there were 
associations of our indicators within the theorized latent constructs. Distress indicators (PHQ9, 
GAD7, PROMIS-Distress Depression, PROMIS-Distress Anxiety) were moderately and 
significantly correlated with one another. See Table 1 and 2. Conceptually, this supported the 
creation of a higher-order factor of general psychological distress. PROMIS-GI subscales were 
also moderately correlated with one another, and this trend was also seen with the WHODAS 
domain subscales. This supports the use of data reduction techniques and the creation of latent 
constructs as demonstrated in this study. 
Age and Biological Sex 
Participants were between the ages of 18-25 years old (N = 861). The sample consisted of 
46.7% males (n = 402), 53.3% females (n = 459). Almost half of participants were 18 years old 
(47.5%). 27.5% of participants reported being 19 years old and 11.6% reported they were 20 
years old.  Additionally, 5.9% of the sample were 21 years old and 2.6% of the sample were 22 
years old, and 2.6% were 23 years old. Only 1.5% of the sample were 24 years old and 0.8% of 





age and biological sex.  There was no statistically significant difference in age between males 
and females t(859) = 1.82, p > .05 in the sample.  
Racial Ethnic Identification  
The sample consisted of 0.35% American Indian/Native American (n = 3), 7.67% 
Asian/Pacific Islander (n = 66), 8.59% Black (n = 74), 52.96% Caucasian (n = 456), 1.39% 
Mexican American (n = 12), 4.88% Puerto Rican (n = 42), 14.17% Hispanic (n = 122), and 
2.09% selected ‘other’ (n = 18).  Of the respondents that selected “other,” respondents self-
identified with the following racial ethnic identities: Arab, Latina, East Indian, Ecuadorian, 
Guyanese, Lebanese, North African, Brazilian, or Middle Eastern.  Lastly, 68 respondents 
identified with multiple racial ethnic identities (7.90%). 
Smoking Status 
123 participants (14.3% of the sample) endorsed smoking (including e-cigarettes and 
vape pens), and 42 participants reported being an ex-smoker (4.9%). The majority of the sample 
(N = 696, 80.80%) reported not smoking.  
Marital Status 
Participants were asked their marital status. Of the sample, only 4 participants reported 
being married, and the overwhelming majority (99.5%) reported being unmarried.  
Physical Health Diagnoses 
Participants were asked if they had been diagnosed with any of the following: Diabetes, 





they had been diagnosed with diabetes (n = 6 males, n = 1 female), 23 reported having IBS (n = 
4 males, n = 19 females), and 7 reported having Celiac Disease (n = 2 males, n = 5 females). The 
majority of participants (93.6%) reported not carrying any of the aforementioned physical 
diagnoses (n = 806) and several reported not knowing (n = 18).   
Classification in College 
Participants were asked their classification in college (i.e., freshman/first-year, 
sophomore, junior or senior). Over half of the sample (55.3%) reported being in their 
freshman/first year of college (n = 476). Sophomore status consisted of 22.4% of the sample (n = 
193), junior status consisted of 14.8% of the sample (n = 127), and seniors were only 7.5% of the 
sample (n = 65).  
Living Status 
Participants were asked with whom they live with during their school year as well as 
location. For options for whom they live with, the following choices were given living alone, one 
or more other students, my spouse/partner, my child/children, parents, relatives, friends who are 
not students, and other people. For location, the following options were given dormitory or other 
campus housing, fraternity or sorority house, residence within driving distance, and residence 
within walking distance. 3.3% of participants identified living alone (n = 28), 68.80% identified 
living with one or more other students (n  = 592), 2.9% reported living with a spouse or partner 
(n = 25), 0.1% reported living with their child/children (n =1), 21.0% reported living with their 
parents (n = 181), 2.2% of respondents reported living with other relatives (n = 19), 0.5% 
reported living with friends who are not students (n = 4), and 1.3% reported living with other 





other campus housing (45.1%, n = 388) compared to living in a residence within driving distance 
(44.4%, n = 382). A small proportion of the participants reported living in a fraternity or sorority 
house (0.8%, n = 7) and in a residence within walking distance (9.80%, n = 84).  
Weight and BMI 
Participants were asked how much they weigh as well as their height. The mean weight 
across both sexes was 155.83 pounds (SD = 39.30). The mean weight for females was 141.26 
pounds (SD = 30.59). The mean weight for males was 172.46 pounds (SD = 41.47). The mean 
height across both sexes was 62.05 inches (5 feet and 2.05 inches). The mean height for females 
was 60.00 inches (5 feet) and the mean height for males was 64.39 inches (5ft and 4.39 inches). 
Then, Body Mass Indices (BMI) were calculated using participant’s reported height and weight.  
The mean BMI across both sexes was 24.03 (SD = 4.93). The mean BMI for females was 
23.71 (SD = 4.73). The mean BMI for males was 24.39 (SD = 5.14). A BMI of less than 18.5 is 
considered underweight, a BMI between 18.5 to 25 is considered normal, and a BMI of 25 to 30 
falls within the overweight range. If a BMI is 30 or higher, it falls within the obese range.  
Then, an independent samples T-test was conducted to compare weight and biological 
sex.  There was a statistically significant difference in weight for females (M = 141.26, SD = 
30.59) compared to males (M = 172.50, SD = 41.52); t(762.60) = 12.41, p < .05. These results 
suggest weight does differ on biological sex in the sample, male participants reported higher 
weight compared to females. This difference was statistically significant. Cohen’s d revealed that 






Table 1: Correlation Table of Variables at Time 1 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 Belly Pain 1                 
2 
Constipation 
.514** 1         
       
3 Diarrhea  .434** .514** 1               
4 
Gas/Bloating 
.541** .470** .401** 1       
       
5 
Nausea/Vomit 
.511** .367** .322** .424** 1      
       
6 Reflux .466** .481** .381** .472**  1            
7 PHQ9 .404** .379** .302** .361** .470** .401** 1           
8 GAD7 .429** .369** .319** .385** .473** .413** .744** 1          
9 PROMIS- 
Depression 
.346** .335** .264** .293** .406** .369** .733** .707** 1  
       
10 PROMIS- 
Anxiety 
.444** .397** .343** .378** .488** .447** .683** .840** .719** 1 
       
11 Cognition .321** .254** .239** .249** .331** .274** .601** .515** .505** .501** 1       
12 Mobility .265** .220** .215** .160** .297** .238** .366** .276** .277** .288** .567** 1      













.321** .309** .286** .233** .362** .359** .611** .530** .506** .513** 
 
.622** .620** .613** .643** .661** 1 
 
17 WHODAS 




.732** .735** .797** .867** .870** 1 






Table 2: Correlation Table of Variables at Time 2 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 Belly Pain 1                 
2 
Constipation 
576** 1                
3 Diarrhea  .564** .563** 1               
4 
Gas/Bloating 
.569** .572** .466** 1              
5 
Nausea/Vomit 
.564** .486** .390** .494** 1             
6 Reflux .503** .525** .452** .536** .580** 1            
7 PHQ9 .413** .444** .305** .382** .487** .417** 1           
8 GAD7 .377** .400** .278** .355** .458** .378** .771** 1          
9 PROMIS-
Depression 
.326** .364** .262** .314** .386** .359** .733** .706** 1         
10 PROMIS-
Anxiety 
.413** .460** .307** .389** .473** .408** .744** .859** .730** 1        
11 Cognition .321** .298** .224** .250** .324** .286** .629** .563** .526** .566** 1       
12 Mobility .264** .231** .253** .176** .322** .262** .399** .347** .311** .328** .532** 1      




.251** .322** .290** .245** .261** .309** .580** .496** .487** .491** .575** .416** .493** 1    
15 Life 
activities 




.313** .343** .298** .250** .368** .330** .604** .561** .490 .545** .584** .561** .603** .652** .701 1  
17 WHODAS 
Score 
.365** .390** .334** .311** .415** .382** .706** .633** .579** .619** .804** .699** .708** .793** .870** .873** 1 












Biological Sex   
Female 459 53.30% 
Male 402 46.70% 
Racial Ethnic Status   
American Indian/Native American 3 0.35% 
Asian/Pacific Islander 66 7.67% 
Black 74 8.59% 
Caucasian 456 52.96% 
Mexican 12 1.39% 
Puerto Rican 42 4.88% 
Hispanic 122 14.17% 
Other (Arab, Latina, East Indian, Ecuadorian, Guyanese, 
Lebanese, North African, Brazilian, or Middle Eastern) 
18 2.09% 
Identified with multiple racial ethnic identities  68 7.90% 
Smoking Status   
Smoker (e-cigarettes and vape pens) 
 
123 14.3% 
Non-Smoker 696 80.80% 
Ex-Smoker 42 4.90% 
Physical Health Diagnoses   
Diabetes 7 0.80% 
Irritable Bowel Syndrome (IBS) 23 2.70% 
Celiac Disease 7 0.80% 
None 806 93.60% 
Reported not knowing 18 2.10% 
Marital Status   
Single (never married) 857 99.50% 
Married/Living with Partner 4 0.50% 
Classification in College   
Freshman/First Year 476 55.30% 
Sophomore 193 22.40% 
Junior 127 14.80% 
Senior 65 7.50% 
Body Mass Index (BMI) M SD 
Females 23.71 4.73 






Table 4: PROMIS-GI T Scores Across Participants 
 
 Time 1  
(N = 861) 
Time 2  
(N = 861) 
Time 1  
Males  
(n = 402) 
Time 2  
Males  
(n = 402) 
Time 1  
Females 
(n = 459) 
Time 2  
Females  
(n = 459) 
 M SD M SD M SD M SD M SD M SD 
Belly Pain 33.90 10.72 43.76 10.74 40.72 8.99 43.19 9.74 48.88 10.84 46.42 11.43 
Constipation  36.60 7.65 44.03 7.98 42.49 6.92 44.94 7.03 47.32 7.99 45.38 8.59 
Diarrhea 39.90 7.09 44.24 6.78 43.47 5.89 44.22 6.38 45.63 7.61 44.92 7.41 
Gas/Bloating 36.70 7.70 48.62 8.39 45.96 7.26 47.29 6.92 53.23 7.27 50.95 8.63 
Nausea/Vomiting 40.60 8.46 46.97 8.10 44.83 6.39 46.46 7.05 50.74 9.07 48.85 8.93 
Reflux/Heartburn 31.20 7.41 43.00 7.43 42.07 6.88 43.26 6.87 44.95 7.77 43.82 7.79 
Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored 
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. Symptom severity categories are mild (T-







Table 5: PROMIS-GI Symptom Classification Across Participants (N = 861) 
Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored as T-
scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-scores were then converted into GI symptom 
severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60 and 70), and 
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Table 6: PROMIS-GI Symptom Classification for Males (n = 402) 
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Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored 
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-scores were then converted into GI 
symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60 









Table 7: PROMIS-GI Symptom Classification for Females (n = 459) 
 Time 1       Time 2 





















































































































































Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored 
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-scores were then converted into GI 
symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60 





Table 8: Depression and Anxiety Scores Across Participants (N = 861) 
 
Time 1  
(N = 861) 
Time 2  
(N = 861) 
Time 1 
Males  
(n = 402) 
Time 2 
Males  
(n = 402) 
Time 1 
Females  
(n = 459) 
Time 2 
Females  
(n = 459) 
 M SD M SD M SD M SD M SD M SD 
PHQ-9 5.94 5.40 4.96 5.14 4.86 4.61 3.94 4.19 6.88 5.85 5.86 5.70 
GAD-7 5.28 5.36 4.43 5.06 3.92 4.46 3.18 4.09 6.47 5.79 5.53 5.56 
PROMIS-
Depression 
50.47 9.72 48.80 9.91 49.36 10.07 47.40 8.97 51.53 10.20 50.03 10.53 
PROMIS-
Anxiety 
52.12 11.45 50.37 11.86 49.36 9.00 47.52 10.28 54.53 12.04 52.86 12.58 
Note. The PHQ-9 summary scores were used (score ranges from 0 to 27). The GAD7 summary scores were used (score ranges from 0 
to 21). The PROMIS-Emotional Distress measures are scored as T-scores. A T score is standardized with a mean of 50 and standard 






Table 9: Depression and Anxiety Symptom Classification Across Participants (N = 861) 
 Time 1     Time 2    































































* * * 
35 
(4.10%) 




































Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal, 
mild, moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe. 
The PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-
scores were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), 













Table 10: Depression and Anxiety Symptom Classification for Males (n = 402) 
 Time 1     Time 2    

































































* * * 
10  
(2.50%) 




































Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal, mild, 
moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe. The 
PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-scores 
were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate 





Table 11: Depression and Anxiety Symptom Classification for Females (n = 459) 
 Time 1     Time 2    

































































* * * 
25 
 (5.40%) 




































Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal, mild, 
moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe. The 
PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.  T-scores 
were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate 









Table 12:  DSM-5 WHODAS Symptom Severity Ranges for Participants (N = 861) 
 Time 1     Time 2  



























































































































































































DSM-5 recommends for interpretation to use average scores for each domain. These average scores are based on a 5-point scale which 
allows the clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3), severe (4), or 
extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of items. The 
average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores were then 
computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate Disability 
Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4, and 






Table 13: DSM-5 WHODAS Symptom Severity Ranges for Males (n = 402) 






















































































































































































DSM-5 recommends for interpretation use only to use average scores for each domain. These average scores are based on a 5-point 
scale which allows a clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3), 
severe (4), or extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of 
items. The average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores 
were then computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate 
Disability Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4, 






Table 14:  DSM-5 WHODAS Symptom Severity Ranges for Females (n = 459) 
 Time 1     Time 2  


























































































































































































DSM-5 recommends for interpretation to use average scores for each domain. These average scores are based on a 5-point scale which 
allows the clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3), severe (4), or 
extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of items. The 
average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores were then 
computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate Disability 
Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4, and 





Gastrointestinal Symptoms and Menses 
Female respondents (n = 459) were given the following item at both Time 1 and Time 2: 
“Please rate the degree to which any gastrointestinal symptoms you reported are related to your 
menstrual cycle.” This item was presented on a Likert scale of 1 (not at all), 2 (a little bit), 3 
(somewhat), 4 (Quite a bit), or 5 (Very much). At Time 1 and Time 2, the modal response on this 
item was 2.  
Medical Treatment Sought for Gastrointestinal Health  
All participants were asked if in the last six months they had sought medical treatment for 
their gastrointestinal health. The majority (92.8%) of participants (n = 799) reported that they 
had not, while a small proportion reported that they had (n = 62, 7.20%). Of those that reported 
having Celiac disease (n = 7), 2 reported seeking out medical treatment for their gastrointestinal 
health. In comparison, of those that reported having IBS (n = 23), 19 reported seeking out 
medical treatment for their gastrointestinal health. Those with Diabetes (n = 7), 1 reported 
seeking medical treatment for their gastrointestinal health.  
Independent Samples T-Tests  
Independent samples t-tests were conducted to determine if there were significant 
differences between gastrointestinal health, psychological distress, and disability when 
comparing males to females. The results of these tests can be found in Tables 15-17. These 
findings revealed several of the symptom scales (GI health, psychological distress, and disability 
subdomains) demonstrated significant differences (p < .05) on biological sex. These differences 





finding statistically significant differences when such differences may be inconsequential in 
nature. As such, effect sizes were reported to show the magnitude of the effect. A Cohen’s d = 
0.2 is considered to be a small effect, d = 0.5 represents a medium effect, and d = .8 is considered 
to be a large effect. In other words, if group means do not substantially differ by 0.02 standard 
deviations these differences, although statistically significant, are negligible (Lakens, 2013).  
Regarding gastrointestinal symptoms, an independent samples t-test was conducted to 
compare group means for males vs. females on the PROMIS-GI symptom subscales (Table 10). 
Females reported statistically significantly higher scores on the PROMIS-GI symptom subscales 
compared to the males in the sample. Cohen’s d effect sizes revealed small effect sizes for these 
differences in constipation, diarrhea, and reflux between males and females. Cohen’s d revealed 
that there a medium effect size for these differences for belly pain (d = .55 at Time 1 and Time 2) 
and nausea and vomiting (d = -.52 at Time 1, d = -.51 at Time 2) between males and females. 
Lastly, Cohen’s d revealed a large effect size (d = -.84) for these differences in gas and bloating 
at Time 1 between males and females and a medium effect size (d = -.62) at Time 2.  See Table 
15. 
Regarding psychological distress, an independent samples t-test was conducted to 
compare group means for males vs. females on the PHQ9, GAD7, PROMIS-Distress Depression, 
and PROMIS-Distress Anxiety (see Table 11). Females reported statistically significantly higher 
scores on the PHQ9, GAD7, PROMIS-Distress Depression, and PROMIS-Distress Anxiety than 
males. Cohen’s d effect sizes revealed small effect sizes for these differences in the PROMIS-
Distress Depression and PHQ9 measure at Time 1 and Time 2. Cohen’s d effect sizes revealed 
there was a medium effect size difference for the GAD7 and the PROMIS-Distress Anxiety 





Regarding disability and functioning levels, an independent samples t-test was conducted 
to compare group means for males vs. females on the WHODAS-Disability domains subscales 
and total score (Table 12).  Males and females did not differ on the self-care and getting along 
with people domain subscales at both Time 1 and Time 2. However, females reported 
significantly higher scores on the disability scales of cognition, mobility, life activities, 
participating in society, and in the general disability functioning total score at both Time 1 and 





Table 15: Results of t-tests for Gastrointestinal Health by Biological Sex 
Variables Men vs Women at Time 1  Men vs Women at Time 2  
95% CI for 
Mean 
Difference 
t df Cohen’s d 95% CI for 
Mean 
Difference 
t df Cohen’s d 
PROMIS-GI         
Belly Pain -7.09, -4.31 -8.07** 859 -0.55 -7.09, -4.31 -8.05** 859 -0.55 
Constipation -3.38, -1.36 -4.61** 859 -0.32 -3.94, -1.84 -5.39** 859 -0.37 
Diarrhea -2.35, -0.46 -2.91** 859 -0.20 -2.35, -0.54 -3.13** 859 -0.21 
Gas and Bloating -6.90, -4.99 -12.25** 859 -0.84 -6.07, -3.92 -9.12** 859 -0.62 
Nausea and 
Vomiting 
-5.38, -3.18 -7.65** 859 -0.52 -5.08, -2.97 -7.51** 859 -0.51 
Reflux and 
Heartburn 
-2.68, -0.71 -3.37** 859 -0.23 -2.74, -0.76 -3.47** 859 -0.24 
** p < .01 
* p < .05 
Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are 






Table 16: Results of t-tests for Psychological Distress by Biological Sex 
Variables Men vs Women at Time 1  Men vs Women at Time 2  
95% CI for 
Mean 
Difference 
t df Cohen’s d 95% CI for 
Mean 
Difference 
t df Cohen’s d 
PHQ-9 -2.73, -1.31 -5.57** 859 -0.38 -2.60, -1.25 -5.57** 859 -0.38 
GAD-7 -3.24, -1.85 -7.15** 859 -0.49 -3.01, -1.69 -6.99** 859 -0.48 
PROMIS-Distress-
Depression 
-3.56, -0.97 -3.44** 859 -0.24 -3.95, -1.32 -3.92** 859 -0.27 
PROMIS-Distress-
Anxiety 
-6.67, -3.68 -6.79** 859 -0.46 -6.89, -3.79 -6.76** 859 -0.46 
** p < .01 
* p < .05 
Note.  The PHQ-9 summary scores were used. The PHQ-9 uses a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every 
day).  Scores range from 0-27.  GAD7 summary scores were used. The GAD7 uses a 4-point Likert scale ranging from 0 (not at all) to 
3 (nearly every day). Scores range from 0-21. Higher scores are indicative of greater depression and anxiety.  The PROMIS-Distress 






Table 17: Results of t-tests for Disability by Biological Sex 
Variables Men vs Women at Time 1  Men vs Women at Time 2  
95% CI for 
Mean 
Difference 
t df Cohen’s 
d 
95% CI for 
Mean 
Difference 
t df Cohen’s d 
WHODAS         
Cognition (6 items) -1.21, -0.06 -2.17* 859 -0.15 -1.44, -0.25         -2.77** 859 -0.19 
Mobility (5 items) -0.78, -0.02 -2.08* 859 -0.14 -0.81, -0.11 -2.54* 859 -0.17 
Self-Care (4 items) -0.46 –0.06 -1.50 859 -0.10 -0.35, 0.15 -0.78 859 -0.05 
Getting Along with 
People (5 items) 
-0.78, 0.17 -1.28 859 -0.09 -0.51, 0.40 -0.24 859 -0.02 
Life Activities (8 
items) 
-1.66, -0.07 -2.14* 859 -0.15 -1.94, -0.45 -3.14** 859 -0.22 
Participating in 
Society (8 items) 
-1.56, -0.19 -2.51* 859 -0.17 -1.46, -0.15 -2.42* 859 -0.17 
General Disability 
Score 
-5.89, -0.68 -2.48* 859 -0.17 -5.94 -0.97 -2.73** 859 -0.19 
** p < .01 
* p < .05 
Note.  WHODAS= World Health Organization Disability Assessment Schedule (WHODAS 2.0). The WHODAS domain specific 
functioning scores were computed by summing the Likert scale scores within each of the domain. The Likert scale was on 1-5 scale.   





CHAPTER SIX: STRUCTURAL EQUATION MODELING RESULTS  
Measurement Models 
Initial confirmatory factor analyses (CFA) were conducted to evaluate the factor structure 
of the latent constructs. Measurement models were conducted separately for each latent construct 
at Time 1 and Time 2 (i.e., GI health, psychological distress, and disability) to evaluate 
standardized factor loadings and overall model fit. The models were estimated with MPlus using 
maximum likelihood estimation. For each CFA, correlated errors terms were allowed between 
the same subscales at Time 1 and Time 2 (for example: belly pain at Time 1 and belly pain at 






Table 18: Measurement Model of Gastrointestinal Health 
PROMIS-GI T Scores at Time 1  Standardized Factor Loadings 
Belly Pain .739 
Constipation .696 
Diarrhea .603 
Gas and Bloating .693 
Nausea and Vomiting .637 
Reflux and Heartburn  .686 
PROMIS-GI T Scores at Time 2 
 
Belly Pain .777 
Constipation .759 
Diarrhea .673 
Gas and Bloating .739 
Nausea and Vomiting .690 
Reflux and Heartburn .704 
Model Fit Indices  
χ2 (df) 208.598 (47) * 




Note.  PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales 
were used. RMSEA = root mean square of approximation; SRMR = standardized root mean 
square residual; TLI = Tucker Lewis index; CFI = comparative fit index; df = degrees of 
freedom; CI = confidence interval. Completely standardized solutions. *represents a significant 
χ2 value with probability of .05. The error terms were allowed to correlate belly pain at Time 1 
and belly pain at Time 2, constipation at Time 1 and constipation at Time 2, diarrhea at Time 1 
and diarrhea at Time 2, gas and bloating at Time 1 and gas and bloating at Time 2, nausea and 
vomiting at Time 1 and nausea and vomiting at Time 2, and reflux at Time 1 and reflux Time 2. 





Table 19: Measurement Model of Psychological Distress 
Psychological distress at 
Time 1 
 Standardized Factor 
Loadings 
PHQ9  .813 
GAD7   .907 
PROMIS-Distress Anxiety  .887 
PROMIS-Distress Depression  .810 




PHQ9   .842 
GAD7   .916 
PROMIS-Distress Anxiety  .910 
PROMIS-Distress Depression  .798 
Model Fit Indices   
χ2 (df)  131.320 (11) * 
RMSEA (90% CI)  .113 (.096–.130) 
CFI  .983 
TLI  .958 
SRMR  .023 
Note. GAD7= Generalized Anxiety Disorder-7 Summary Score, PHQ9- Patient Health 
Questionnaire -9 Summary Score, PROMIS Distress Anxiety T Score, & PROMIS Distress 
Depression T Score RMSEA = root mean square of approximation; SRMR = standardized root 
mean square residual; TLI = Tucker Lewis index; CFI = comparative fit index; df = degrees of 
freedom; CI = confidence interval. Completely standardized solutions. *represents a significant 
χ2 value with probability of .05. The error terms were allowed to correlate: PHQ9 summary score 
at time 1 and PHQ9 summary score at time 2, GAD7 summary score at Time 1 and GAD7 
summary score at Time 2, PROMIS-Distress Anxiety T score at Time 1 and PROMIS-Distress 
Anxiety T score at Time 2, PROMIS Distress Depression T score at Time 1 and PROMIS 
Distress-Depression T score at Time 2, PHQ9 summary score at Time 1 and PROMIS Distress 
Depression T score at Time 1, PHQ9 summary score at Time 2 and PROMIS Distress 
Depression T score at Time 2,  GAD7 summary score at Time 1 and PROMIS Distress Anxiety 
T score at Time 1, and GAD7 summary score at Time 2 and PROMIS Distress Anxiety T score 






Table 20: Measurement Model of Disability 




Getting Along with People .764 
Life Activities .796 
Participating in Society .833 





Getting Along with People .755 
Life Activities .808 
Participating in Society .852 
Model Fit Indices  
χ2 (df) 364.834 (47) * 




Note.  WHODAS = World Health Organization Disability Assessment Schedule. RMSEA = root 
mean square of approximation; SRMR = standardized root mean square residual; TLI = Tucker 
Lewis index; CFI = comparative fit index; df = degrees of freedom; CI = confidence interval. 
Completely standardized solutions. *represents a significant χ2 value with probability of .05. The 
error terms for the following were allowed to correlate: cognition summary score at Time 1 with 
cognition summary score at Time 2, mobility summary score at Time 1 with mobility summary 
score at Time 2, self-care summary score at Time 1 and self-care summary score at Time 2, 
getting along with people summary score at Time 1 and getting along with people summary 
score at Time 2, life activities summary score at Time 1 and life activities summary score at 
Time 2, and participating in society summary score at Time 1 and participating in society 






Testing Measurement Equivalence Across Time 
Testing for measurement equivalence across time is done by performing sequential and 
increasingly constrained confirmatory factor analyses (CFAs), where model constraints are 
increasingly imposed on subsequent measurement models (Cadiz et al., 2009; Wang & Russell, 
2005). Establishing measurement equivalence across time ensures assures comparisons made 
between latent variable relationships are valid across time. The present study used the steps 
outlined in (Vandenberg & Lance, 2000) as well as (Van de Schoot et al., 2012) for testing for 
measurement equivalence. Sequential testing was done by conducting three separate models: 
Model 1 (configural invariance), Model 2 (metric invariance), and Model 3 (scalar invariance). 
Establishing measurement equivalence was performed on each of the study’s latent constructs 
and the results will be presented separately (see Tables 21-23).   
Studies have examined criterion to establish the strength and/or presence of measurement 
equivalence across time (Cadiz et al., 2009; Van de Schoot et al., 2012; Vandenberg & Lance, 
2000; Wang & Russell, 2005). In the current study, the chi-square test (χ 2) was not used as a 
criterion for measurement equivalence. This was due to its sensitivity to sample size (Kline, 
2015). As the present study has a large sample size (N = 861), the use of χ 2 test's may have 
resulted in significant changes in fit where such changes could be inconsequential. As such, 
alternate fit indices were used to evaluate change in model fit after each constraint was placed on 
the nested models (i.e. Model 1- Model 3; (Cheung & Rensvold, 2002). The fit indices used were 
RMSEA, TFI, CFI, and SRMR (Cheung & Rensvold, 2002). The progress change in CFI (ΔCFI) 
was used as an indicator of comparative fit for each model. Multiple criteria for the cut-off value 
for ΔCFI have been presented in previous research. A ΔCFI larger than .002 (Meade et al., 2008) 





of ΔCFI of no greater than .01 (Cheung & Rensvold, 2002). The present study used ΔCFI of no 
greater than .01 to assess comparative fit across the models as well as evaluating the overlap of 
the 90% confidence intervals of RMSEA. A |ΔRMSEA| value ≥ .015 is also evidence for non-
invariance (Chen, 2007).  χ 2 values will be presented in Tables 21-23 but were not used as 
indicators for model fit of measurement equivalence. Measurement equivalence across time 
results can be found in Tables 21-23 
GI Health Latent Construct- Measurement Equivalence Model Results 
Initially, configural invariance was tested, where no constraints are placed on the model 
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 15 for 
initial measurement model. See Table 21 for results of testing for measurement equivalence 
across time. Results demonstrated acceptable fit for the configural invariance model (Model 1) 
(RMSEA = .063; SRMR = .036; TLI = .963; CFI= .974).  
The metric invariance model (Model 2) was tested by constraining factor loadings to be 
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model 
2) were compared. The metric invariance model did not result in significantly worse fit (ΔCFI = 
-.001), supporting weak measurement equivalence. Additionally, the RMSEA confidence 
intervals overlapped (configural invariance 90% CI: .055 - .072, metric invariance 90% CI: .053-
.069).  
The third model was the scalar model (Model 3), in which the first factor mean was 
constrained to be zero to be able to estimate all the factor intercepts. The ΔCFI (-.003) met the 
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CIs for the 





invariance RMSEA 90% CI = .053 - .069. According to Chen (2007) a |ΔCFI| value ≥ .01 in 
addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA 
values did not meet these change criteria (Chen, 2007). Previous work has found that RMSEA 
values can be inflated when models contain a larger number of items. This has been evaluated 
with PROMIS measures and the degree to which they conform with the IRT assumption of 
unidimensionality. This work has noted that the RMSEA index may not be an accurate indicator 
of dimensionality of the large item banks of PROMIS measures (Amtmann et al., 2010; Cook et 
al., 2009). Thus, it can be concluded the latent construct of gastrointestinal health using the six 
PROMIS-GI six symptom subscales as indicators was measured similarly at Time 1 and Time 2.  











PROMIS-GI           
1. Configural 
invariance 
208.598 -- 47 .063 (.055, 
.072) 
.036 .963 .974  
2. Metric 
invariance 
218.701 10.103 52 .061 (.053, 
.069) 
.044 .966 .973 -.001 
3. Scalar 
invariance 
240.030 21.329 57 .061 (.053, 
.069) 
.050 .966 .970 -.003 
Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales 
were used.  df= degrees of freedom; RMSEA = root mean square of approximation; CI = 
confidence interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI = 
comparative fit index; SRMR = standardized root mean square residual; ΔCFI = change in CFI; 
Δχ2 = change in χ2; ΔCFI < .002 and ΔCFI < .01 represents cut-offs for comparative fit.  






Psychological Distress Latent Construct- Measurement Equivalence Model Results 
Initially, configural invariance was tested where no constraints are placed on the model 
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 19 for 
initial measurement model. See Table 22 for results of testing for measurement equivalence 
across time. Results demonstrated reasonable fit for the configural invariance model (Model 1) 
(RMSEA = .113; SRMR = .023; TLI = .958; CFI = .983).  
The metric invariance model (Model 2) was tested by constraining factor loadings to be 
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model 
2) were compared. The metric invariance model did not result in significantly worse fit (ΔCFI = 
-.001), supporting weak measurement equivalence. Additionally, the RMSEA confidence 
intervals overlapped (configural invariance 90% CI: .096 - .130, metric invariance 90% CI: (.09 - 
.121).  
The third model was the scalar model (Model 3), in which the first factor mean was 
constrained to zero to be able to estimate all the factor intercepts. The ΔCFI (-.001) met the 
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CI’s for the 
metric and scalar models overlapped (metric invariance RMSEA 90% CI= .090 - .121; scalar 
invariance RMSEA 90% CI= .082 - .110). The comparison of Model 2 to Model 3 supports the 
conclusion of strong measurement equivalence. According to Chen (2007) a |ΔCFI| value ≥ .01 
in addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA 
values did not meet these change criteria for non-invariance. Given that the RMSEA Confidence 
Intervals did overlap, it can be concluded that measurement equivalence was met (Chen, 2007). 





measures (GAD7, PHQ9, NIH PROMIS Emotional Distress-Anxiety, NIH PROMIS 
Emotional Distress- Depression) was measured similarly at Time 1 and Time 2.  













131.320 -- 11 .113 (.096, 
.130) 
.023 .958 .983  
2. Metric 
invariance 
147.763 16.443 14 .105 (.090, 
.121) 
.033 .963 .982 -.001 
3. Scalar 
invariance 
152.391 4.628 17 .096 (.082, 
.110) 
.032 .969 .981 -.001 
Note. GAD7= Generalized Anxiety Disorder-7 Summary Score, PHQ9- Patient Health 
Questionnaire -9 Summary Score, PROMIS Distress Anxiety T Score, & PROMIS Distress 
Depression T Score were used to create a higher-order latent construct of Psychological 
distress; df= degrees of freedom; RMSEA = root mean square of approximation; CI = confidence 
interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI = comparative fit index; 
SRMR = standardized root mean square residual; ΔCFI = change in CFI; Δχ2 = change in χ2; 
ΔCFI < .002 and ΔCFI < .01 represents cut-offs for comparative fit.  
Disability Outcome Latent Construct- Measurement Equivalence Model Results 
Initially, configural invariance was tested, where no constraints are placed on the model 
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 20 for 
initial measurement model. See Table 23 for results of testing for measurement equivalence 
across time. Results demonstrated acceptable fit for Model 1 (configural invariance model) 
(RMSEA = .089; SRMR = .047; TLI = .941; CFI = .958). These results indicate that the overall 
latent factor structure of disability fits well for the study sample.  
The metric invariance model (Model 2) was tested by constraining factor loadings to be 
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model 





-0.000). Additionally, the RMSEA confidence intervals overlapped (configural invariance 90% 
CI: .08, .097; metric invariance 90% CI: .076, .093).  
The third model was the scalar model (Model 3), in which the first factor mean was 
constrained to zero to be able to estimate all the factor intercepts. The ΔCFI (-.000) met the 
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CI’s for the 
metric and scalar models overlapped (metric invariance RMSEA 90% CI= .076, .093; scalar 
invariance RMSEA 90% CI= .073, .089). According to Chen (2007) a |ΔCFI| value ≥ 0.01 in 
addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA 
values did not meet these change criteria for non-invariance. Given that the RMSEA confidence 
intervals did overlap, it can be concluded that measurement equivalence was met (Chen, 2007). 
Results indicate the measurement of the latent construct of Disability using the six WHODAS 



















364.834 -- 47 .089 (.08, 
.097) 
.047 .941 .958  
2. Metric 
invariance 
371.330 6.496 52 .084 (.076, 
.093) 
.049 .946 .958 -.000 
3. Scalar 
invariance 
376.641 5.311 57 .081 (.073, 
.089) 
.049 .951 .958 -.000 
Note. WHODAS = World Health Organization Disability Assessment Schedule, the six scales were used to create a 
higher-order latent construct of Disability; df= degrees of freedom; RMSEA = root mean square of approximation; 
CI = confidence interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI = comparative fit index; 
SRMR = standardized root mean square residual; ΔCFI = change in CFI; Δχ2 = change in χ2; ΔCFI < .002 and ΔCFI 
< .01 represents cut-offs for comparative fit.  
Cross-Lagged Panel Model 
Correlated Errors  
A cross-lagged panel SEM was then specified to assess for temporal relationships 
between gastrointestinal health, psychological distress, and disability. Modification indices were 
examined, and correlated error terms were iteratively freed.  Freeing correlated errors were 
theory-driven rather than data-driven. For example, given that measurement was conducted on 
two occasions, Time 1 and Time 2, it was not surprising correlated residuals of the repeated 
measures were found across time. Researchers administering repeated measures in longitudinal 
design is common, therefore it is expected the indicator residuals (IRs) of these measures would 
correlate across time (Landis et al., 2009). The freeing of these correlations is less problematic as 
they would be of cross-sectional data, as the “…residual variance can be portioned into random 
and systematic error.” (Landis et al., 2009) Guided by these empirical recommendations, 
correlations were allowed between the same measures at Time 1 and Time 2 as they had identical 
content. For example, scores on the PHQ9 at Time 1 could correlate with scores at Time 2. 





variable counterpart at Time 2 (GI health at Time 1 was allowed to correlate with GI health at 
Time 2). Two additional errors were allowed to correlate: psychological distress correlating with 
Mobility WHODAS subscale and PHQ9 (depression measure) predicting disability.  Research 
has shown a strong relationship between depression (psychological distress) and physical 
disabilities. More specifically, physical disability is operationally defined as experiencing 
impairment in activities in daily living (ADL) and in mobility. A seminal longitudinal study 
investigated a cohort of non-disabled subjects (N = 6247) and found depressed individuals at 
baseline were more likely to be less physically active compared to non-depressed individuals. At 
a 6 year follow up, depressed individuals were significant more likely to have impairment in 
ADL and in mobility disability (Penninx et al., 1999). Additionally, depression has been cited as 
the leading cause of disability around the world by the World Health Organization (Behrens-
Wittenberg & Wedegaertner, 2020). Depression has been associated with significant disability 
and burden across physical diagnoses (Behrens-Wittenberg & Wedegaertner, 2020; Ericsson et 
al., 2002; Reddy, 2010). A correlated error implies residuals (error terms) are correlated with 
variables in the model and with each other which implies a non-directional relation whereas a 
unidirectional path implies causality.  As these correlated errors have theoretical basis, they were 
allowed to correlate. Additional correlated error terms may have significantly decreased χ2, 
however, these lacked theoretical basis.  
Biological Sex Covariate 
Due to the ubiquitous significant differences in biological sex found across the measures 





cross-lagged paths. This covariate was included to control for the variance associated with 
biological sex.   
Model 1: Autoregressive Paths 
 Model 1 (M1) was an autoregressive model with no cross-lagged effects, also known as a 
baseline or stability model. This model assumes that the predictor of the variable at Time 1 (T1) 
is the same variable at Time 2 (T2) and demonstrates temporal stability of the variables over 
time. All three autoregressive paths were statistically significant. The GI health construct was 
stable across the two time points (β= .822, SE= .029, p < .001). Psychological distress (β = .875, 
SE = .024, p < .001) and disability (β = .856, SE = .027, p < .001) exhibited significant stability.   
Model 2: Cross-Lagged Model 
Model 2 (M2) was a cross-lagged model extending M1 by adding cross-lagged paths 
from GI health at T1 to psychological distress at T2, psychological distress at T1 to disability at 
T2, and GI health at T1 to disability at T2. The autoregressive paths remained significant: GI 
health: (β = .808, SE = .033, p < .001), psychological distress (β= .791, SE = .071, p < .001), and 
disability (β= .660, SE = .06, p < .001). One significant cross-lagged path was found in Model 2: 
GI health at Time 1 significantly predicted disability at Time 2 (β = .133, SE = .04, p < .01). The 
two other cross-lagged paths were non-significant. GI health at Time 1 did not predict 
psychological distress at Time 2 (β = .073, SE = .052, p = .166). Psychological distress at Time 1 
did not predict disability at Time 2 (β = .085, SE = .056, p = .125). Biological sex was not 





Model 3: Reverse Cross-Lagged Model 
Model 3 (M3) was a reverse cross-lagged model where reverse cross-lagged paths were 
run with the autoregressive statements. Reverse cross-lagged paths were added from 
psychological distress at T1 to GI health at T2 and disability at T1 to psychological distress at 
T2.  The path of GI health at T1 to disability at T2 remained in the model. The autoregressive 
pathways remained stable and significant GI health: (β= .472, SE = .127, p < .001), 
psychological distress (β= .819, SE = .031, p < .001), and disability (β = .752, SE = .034, p < 
.001). Both reverse cross-lagged paths were significant: psychological distress at T1 predicted GI 
health at T2 (β = .221, SE = .082, p < .01) and disability at T1 predicted psychological distress at 
T2 (β = .095, SE = .026, p < .001). Lastly, the pathway between GI health at T1 to disability at 
T2 remained significant (β = .132, SE = .033, p < .001). Biological sex was a significant 
covariate in predicting psychological distress at T2 (p = .044) but non-significant in all other 
paths.   
Model 4: Reciprocal Cross-Lagged Model  
Model 4 (M4) was a reciprocal cross-lagged model including all autoregressive and 
cross-lagged paths from M1 to M3 (Van de Schoot et al., 2012; Vötter & Schnell, 2019). The 
autoregressive pathways remained stable and significant, GI health: (β = .500, SE = .1279, p < 
.001), psychological distress (β = .763, SE = .069, p < .001), and disability (β = .691, SE = .059, 
p < .001). Three significant cross-lagged paths were found. Psychological distress at T1 
significantly predicted GI health at T2 (β = .206, SE = .084, p < .05). GI health at T1 
significantly predicted disability at T2 (β = .117, SE = .039, p < .01).  Lastly, disability at T1 
significantly predicted psychological distress at T2 (β = .092, SE = .027, p < .01). GI health at T1 





psychological distress at T1 did not predict disability at T2 (β = .065, SE = .056, p = .242.  
Biological sex was not significant in any path in Model 4 (p > .05).  
Table 24 shows the fit indices for Models 1-4. Table 25 shows an overview of the 
standardized stability and cross-lagged coefficients. Figure 2 illustrates the standardized 






Table 24: Fit Indices for CLPM 1–4 with Latent Variables: Gastrointestinal Health, 
Psychological distress, and Disability 
Model χ2 df p RMSEA SRMR CFI TLI 
Model 1 1886.725 469 .0000 .059 .098 .938 .930 
Model 2 1857.398 464 .0000 .059 .090 .939 .931 
Model 3 1839.593 463 .0000 .059 .089 .940 .931 
Model 4 1837.007 461 .0000 .059 .089 .940 .931 
 
  
Table 25: Overview of the Standardized Stability and Cross-Lagged Coefficients 
Model Autoregressive path β Cross-lagged path  β 
1 GHT1                       GIHT2 .822***   
 PSYT1            PSYT2 .875***   
 DIST1             DIST2 .856***   
2 GHT1            GHT2 .808*** GHT1                PSYT2 .073 
 PSYT1           PSYT2 .791*** PSYT1                DIST2 .085 
 DIST1            DIST2 .660*** GHT1                 DIST2 .133** 
3 GHT1             GHT2 .472*** PSYT1                GHT2 .221** 
 PSYT1           PSYT2 .819*** DIST1                          PSYT2 .095*** 
 DIST1            DIST2 .752*** GHT1                 DIST2 .132*** 
4 GHT1             GHT2 .500*** GHT1                PSYT2 .046 
 PSYT1           PSYT2 .763*** PSYT1               GHT2 .206* 
 DIST1            DIST2 .691*** PSYT1               DIST2 .065 
   DIST1                          PSYT2 .092** 
   GHT1                 DIST2 .117** 
GH = GI health, PSY = psychological distress, and DIS = disability; T1 = Time 1 and T2 = Time 2. Standardized coefficients (β) of all 
significant paths.  








Figure 2: Final Cross-Lagged Panel Model Results 
Note. Two-wave cross-lagged panel model between GI health, psychological distress, and disability (Model 4). This figure includes 
standardized coefficients (β) of all significant paths of Model 4 (continuous lines). Gray dashed lines represent the non-significant 

















CHAPTER SEVEN: DISCUSSION  
This is the first study of its kind to investigate temporal relationships between latent 
constructs of gastrointestinal health, psychological distress, and disability in a large sample of 
emerging adults. This study had several strengths. First, the large sample size (N = 861) across 
two time points allowed for an exploration of latent constructs using SEM methodology. This 
exploration revealed construct validity for three latent constructs. These latent constructs were 
GI health (with the use of six PROMI-GI symptom subscales), higher order psychological 
distress (PHQ9, GAD7, PROMIS-Distress Depression, PROMIS-Distress Anxiety), and 
disability (with the use of the six WHODAS domains of functioning). Measurement equivalence 
results showed these three latent constructs were measured similarly at the two time points. The 
results of the CLPM demonstrated autoregressive temporal stability (constructs were stable 
across two time points) and predictive power (constructs showed meaningful relationships with 
one another).  
Establishing unidimensional latent variables is clinically meaningful. Many commonly 
used measures do not reliably distinguish symptoms of anxiety and depression due to their highly 
related nature. This, as previously discussed, is supported empirically (Cosco et al., 2012; 
Teymoori et al., 2020; Wright et al., 2013). The results in this study show a higher order 
construct of psychological distress can be created with four self-report measures (PHQ9, GAD7, 
PROMIS-Distress Depression, PROMIS-Distress Anxiety). This aligns with the National 
Institute of Mental Health’s (NIMH) Research Domain Criteria (RDoC) initiative to create 
classification of mental disorders on dimensions. The development of a unidimensional 
psychological distress construct using patient reported outcomes (PROs) is consistent with these 





The creators of WHODAS have published the WHODAS factor structure, confirming the 
six domains loading on a general disability factor and the unidimensionality of this measure 
(Üstün et al., 2001; Üstün, Kostanjsek, et al., 2010).  This study confirms this factor structure. 
The psychometric evidence presented in this study established measurement equivalence across 
time, temporal stability, and predictive power with the latent construct of disability. 
The creation of a GI health construct was guided by a previous study conducted by the 
author. The previous study found preliminary evidence of a latent construct titled GI health using 
the six PROMIS-GI scales (Ross et al., 2020). This previous study was limited because it used 
cross-sectional data. The current study supports this previous work and extends its findings. 
Measurement equivalence results showed GI health was measured similarly across time. 
Additionally, the CLPM results demonstrated autoregressive temporal stability and predictive 
power of GI health. These findings have theoretical and clinical implications. As identified in the 
literature review, gastrointestinal symptoms of DGBI tend to fluctuate across symptoms 
domains. This has limitations in clinical settings, as patients may present with one dominant 
symptom and then fluctuate to another symptom the next. For example, a patient may be 
diagnosed with IBS-C or IBS-D subtype but fluctuate significantly across diagnostic domains. 
The creation of a latent construct of GI health may better capture the true symptom experience in 
patients with DGBI.  
GI Health and Psychological Distress  
There is evidence for a link between psychological distress and gastrointestinal health in 
this sample of emerging adults. The significant cross-lagged pathway from psychological distress 





higher GI symptom experience at Time 2 (controlling for biological sex). The cross-lagged effect 
lends some preliminary evidence gastrointestinal symptoms may be a consequence of 
psychological distress in emerging adults. The findings highlighted the predictor power of 
psychological distress on gastrointestinal health across time. This significant cross-lagged path 
supports the inference of temporal precedence and causality, as higher reported psychological 
distress led to higher GI health.  However, the reciprocal pathway hypothesis of GI health at 
Time 1 predicting psychological distress at Time 2 was not supported. The data did not show a 
significant cross-lagged path from GI health at Time 1 to psychological distress at Time 2. 
Consequently, it appears in this sample, it can be inferred psychological distress preceded GI 
health over time. Previous research has highlighted the strong association between psychological 
distress and GI symptomatology for DGBI. However, these studies have limitations as they 
utilize a cross-sectional design. Subsequently, previous work likely has not adequately controlled 
(statistically) for prior distress when predicting future distress from GI symptoms. The advantage 
of this study is it can make stronger causal inferences than a traditional cross-sectional design 
that has been previously used to examine these relationships in DGBI (Banerjee et al., 2017; 
Midenfjord et al., 2019; Patel et al., 2015; Qin et al., 2014; Simon et al., 1996; Spiegel et al., 
2008). 
Psychological Distress and Disability 
A significant cross-lagged pathway from disability at Time 1 to psychological distress at 
Time 2 was found. This indicated higher levels of self-reported disability predicted greater 
psychological distress at Time 2 among the sample. There was a pattern of significant (disability 





1 to disability at Time 2) cross-lagged pathways. This significant cross-lagged path supports the 
inference of temporal precedence and causality, as higher reported disability symptoms led to 
higher psychological distress. Findings highlight the predictive power of disability on 
psychological distress across time. It appears that in the sample, disability preceded 
psychological distress over time.  There was no evidence of bidirectionality and reciprocal 
causality between psychological distress and disability.  
GI Health and Disability 
In support of initial hypotheses, GI health at Time 1 predicted disability at Time 2. The 
significant cross-lagged pathway from GI health at Time 1 to disability at Time 2 indicated 
higher self-reported GI symptoms at Time 1 predicted higher levels of disability at Time 2 
among this sample of emerging adults. This significant cross-lagged path supports the inference 
of temporal precedence and causality, as higher reported gastrointestinal symptoms led to higher 
disability. 
Biological Sex Differences 
Descriptive analyses (independent sample t-tests) suggested biological sex differences in 
several of our measures. However, Cohen’s d effect size computations indicated many of these 
differences were small to medium in nature. The final CLPM results showed biological sex was 
not a significant covariate in any paths of interest. Therefore, it can be concluded results 
presented here adequately controlled for the variance associated with biological sex.  A future 
study could test for measurement equivalence across biological sex. This type of analysis would 





Of potential interest could be overlap of female’s menstrual pain with self-reported GI 
symptom experience. A recent study conducted in the Health Psychology Lab found no 
significant multivariate differences in GI symptoms using the PROMIS-GI scales across three 
phases of the menstrual cycle. The study investigated three groups of emerging adult females (N 
= 531) during the Menstrual, Luteal, and Follicular phase of their menstrual cycle. No significant 
multivariate differences were found in the PROMIS-GI scales across the three groups, indicating 
the PROMIS-GI scales do not discriminate between phases of the menstrual cycle (Anbukkarasu, 
Cassisi, and Zaman, 2021).  
Limitations 
The choice of time lag period in this study has limitations. One of the fundamental 
choices for using CLPM is when to measure research participants and choice of the time lag. 
These relationships may exist and play out across varying time periods. A future study may need 
to consider modulating time lags to assess for this. For example, the relationship between 
impairment in functioning and distress may play out across several weeks whereas GI symptoms 
may need to be captured at the momentary and/or daily level.  Additionally, this study used a 
two-wave measurement. A study design with more frequent assessment over time may provide 
even better information as to best timing and targets for intervention. The present study was 
limited to the recall period described by each measure used.  An extension of the current study 
could employ the use of ecological momentary assessment (EMA) that would involve repeated 
measures of symptoms in a participant’s real time. A study with more frequent assessment 





study could employ a random-intercept cross-lagged panel model methodology or latent growth 
curve modeling. These procedures require a minimum of three waves of measurement.  
Relying on self-report measures is necessary for investigating emotional states. However, 
utilizing self-report measures does raise potential issues. Limitations include relying on a 
participant’s recall bias, level of self-awareness, and insight. Despite these potential limitations 
in utilizing self-report measures, relying on self-report is essential in research studies such as this 
one. Patient-reported outcomes (PROs) quantify how a patient perceives many domains in their 
life and are extensively used to determine an intervention’s success. An advantage to the self-
report measures used in this study are they are commonly used in healthcare settings. As such, 
future studies could replicate these findings as the PROs used in this study are easily accessible 
and freely available.  
Another limitation of the present study is the sample. Data was collected from a sample 
representative of the diversity at the university which did not include a clinical sample. Despite 
this, the emerging adult sample presented with a range of gastrointestinal, anxiety, depressive, 
and disability levels. The advantage of a non-clinical sample is it promoted an investigation of 
theory-based questions (biopsychosocial and gut-brain axis model). However, results may not 
generalize to other subgroups of an adult population. Additionally, emerging adults may be 
experiencing additional stressors that this study did not account for. A future study could 
investigate the effect of trait anxiety (Söderquist et al., 2020) and/or external stressors (Saleh et 
al., 2017) in emerging adults. Future research with a wider range of adults as well as symptom 
presentations would allow for a greater understanding of these variables. 
One of the strengths of this study was the creation of latent variables using symptom 





Anxiety, and the WHODAS). Findings show great promise in the psychometric and predictive 
power of grouping these scales into latent variables. However, the grouping of symptom 
measures in this way does forgo an analysis of symptom classes and severity groupings. An 
extension of this study could utilize latent class analysis (LCA) to identify different symptom 






CHAPTER EIGHT: CONCLUSIONS 
The aim of this study was to establish the relationship between gastrointestinal health, 
psychological distress, and disability across two time points in an emerging adult sample. 
Findings indicated there was a significant cross-lagged pathway between psychological distress 
at Time 1 to GI health at Time 2. This indicated gastrointestinal symptoms were a consequence 
of psychological distress in the sample. A significant cross-lagged pathway between 
psychological distress and disability was found, demonstrating higher levels of self-reported 
disability predicted greater psychological distress at Time 2. Lastly, results indicated a 
significant cross-lagged pathway from GI health to disability. This suggested higher self-reported 
GI symptoms at Time 1 predicted higher levels of disability at Time 2.  
The absence of significant reciprocal pathways inferred a directional pathway between 
the brain and the gut rather than a bidirectional pathway in this sample. This signaling seems to 
be stronger from the brain to the gut compared to the gut to the brain in emerging adults. These 
findings offer only partial support for the GBA model. Alternatively, this study implies a more 
appropriate label for the emerging adult sample may be “BGA” (brain-gut axis). These findings 
could suggest a traditional psychosomatic perspective rather than supporting the bidirectionality 
postulated by the GBA.  The data in this study showed psychological distress was an antecedent 
of gastrointestinal health rather than a showing a reciprocal relationship.  This study is consistent 
with previous research findings which have conceptualized IBS-like symptoms as driven by the 
brain and as a stress-sensitive disorder (Qin et al., 2014). However, previous studies have not 
controlled for existing distress as this current study did. Gastrointestinal symptoms have emerged 
as one of the most dominant somatic symptom clusters associated with distress (Simon et al., 





psychosocial variables. Higher psychological distress can lead to an increased stress-response, 
inflammation, and arousal of the autonomic nervous system (Koloski et al., 2016; Lucas, 2018; 
Mayer et al., 2015; Won & Kim, 2016). These physiological mechanisms of action have the 
potential of leading to higher self-reported gastrointestinal symptoms. The significant finding of 
GI health leading to increased disability over time indicated GI symptoms also accompany 
functional limitations.  Overall, findings highlight the role of psychological distress as a strong 
contributing factor to GI symptom experience as well as overall functioning.  
Clinical Implications 
A focus on integrative treatment guided by the biopsychosocial model is essential for 
individuals facing significant psychological distress and gastrointestinal difficulties. There is an 
imperative to offer evidence-based, brain-gut psychotherapies to individuals with DGBI. 
Currently, there is only 219 registered GI behavioral health providers (and only 7 in Florida), 
with even fewer being licensed clinical psychologists. The Rome Foundation GastroPsych 
Section has developed an initiative to expand education to providers. The temporal order of the 
latent constructs found in this study suggests a direction for psychological assessment and 
treatment in emerging adults. These study’s findings propose inquiry regarding GI functioning as 
well as providing appropriate psychoeducation about the gut-brain connection may need to be 
included as standard of care in student health services. It would not be a significant burden on 
typical clinical care for a clinician to include a GI assessment measure, such as the PROMIS-GI, 
to capture the overall GI functioning of their patients.  Brain-gut psychotherapy treatment 
options for DGBI with the strongest evidence base include mindfulness-based therapies, 





(Ballou & Keefer, 2017; Gaylord et al., 2011; Naliboff et al., 2020). Psychodynamic and 
interpersonal therapies have also been tested but have a weaker evidential base. Additional 
psychological treatment components may include psychoeducation and exposure-based elements 
(Boersma et al., 2016; Craske et al., 2011). Exposure-based therapies incorporate interoceptive 
exposure to visceral sensations or target avoidance for those fearful of having a bowel movement 
in a public restroom or while going about their daily activities (Boersma et al., 2016; Craske et 
al., 2011). Providing a strong and compelling rationale for treatment would involve appropriate 
psychoeducation about the gut-brain connection. This may help normalize an individual’s GI 
experience, decrease embarrassment and stigmatization. It is recommended a clinician discuss 
the interconnected network between the brain and gut to their patients and explain this system 
can become dysregulated by chronic stress. A clinician could frame GI symptoms are a 
burdensome and common occurrence for a large portion of the population; even those that do not 
carry a formal GI disorder diagnosis. Anecdotally, most healthy individuals often experience 
abdominal discomfort and changes in their bowels when they experience psychological distress. 
Notably, long-term psychological distress has the potential of changing the homeostasis of the 
gastrointestinal system (Chong et al., 2019; Zhou & Verne, 2011; Zhuang et al., 2017). Taken 
together, brain-gut psychotherapies are an efficacious treatment option for patients with DGBI.   
This study offers an empirical explanation for the interplay of self-reported 
gastrointestinal symptoms, psychological distress, and disability across two points in time in 
emerging adults. Results suggested self-reported GI symptoms seem to be a consequence of 
psychological distress in this sample. Findings also indicated GI symptoms accompany 
interference in functioning over time.  These findings highlight the importance of 
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